The QualityStocks Daily Tuesday, April 4th, 2023

Today's Top 3 Investment Newsletters

QualityStocks(IFRX) $3.7700 +83.90%

Schaeffer's(CDLX) $6.2400 +80.87%

MarketClub Analysis(BFRG) $6.0000 +27.93%

The QualityStocks Daily Stock List

NanoViricides (NNVC), Wall Street Resources, QualityStocks, StockMarketWatch, Stock Preacher, PennyStocks24, Beacon Equity Research, InvestorSoup, MarketClub Analysis, BUYINS.NET, TradersPro, Jason Bond, SuperStockTips, StockProfessors, Penny Stocks Finder, StockHideout, Penny Stock Craze, MissionIR, SmarTrend Newsletters, MarketBeat, Stock Roach, LightningStockPicks, PennyStockShark, Stock Analyzer, FeedBlitz, CoolPennyStocks, USA Market News, Standout Stocks, HotOTC, Tiny Gems, TopStockAnalysts, Market Wrap Daily, Broad Street, PennyOmega, OTCPicks, Penny Stock Finder, ProTrader, StreetAuthority Daily, All about trends, InvestorPlace, HotStockChat, Stock Beast, Greenbackers, Stock Market Watch, DrStockPick, CRWEWallStreet, CRWEFinance, OTCReporter, AllPennyStocks, The Street, Stockwire, Stock Rich, BullRally, Stock Source, BestOtc, StockEgg, CRWEPicks, MicroCapDaily, Zacks, StreetInsider, Agora Financial, PennyTrader Publisher, ProfitableTrading, Penny Pick Finders, Penny Invest, SmallCapVoice, MicrocapVoice, InvestorsUnderground, MegaPennyStocks, The Online Investor, MarketClub, Real Pennies, RedChip, Round Up the Bulls, PennyToBuck and StockHotTips reported earlier on NanoViricides (NNVC), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

NanoViricides Inc. (NYSE American: NNVC) (FRA: NV3P) is a nano-biopharmaceutical firm that is engaged in the discovery, development and commercialization of therapies for treating viral infections and helping advance the care of patients with these life-threatening ailments.

The firm has its headquarters in Shelton, Connecticut and was incorporated in 2005, on April 1st by Anil R. Diwan. It operates in the health care sector, under the biotech and pharma sub-industry.

The company centers its clinical programs and research on certain anti-viral therapies and is working on adding to them its current portfolio of products via an in-licensing strategy and its clinical development and internal discovery programs. It is currently engaged in the application of Nano medicine technologies to the intricate issues of viral illnesses.

The enterprise’s product pipeline is made up of an anti-HIV nanoviricide dubbed HIVCide; DengueCide developed for treating all Dengue viruses; Nanoviricide eye drops for viral ailments that affect the external eye; and an injectable and an anti-influenza oral broad-spectrum nanoviricide known as FluCide, developed for both outpatients and hospitalized patients. The enterprise also develops a treatment for viral acute necrosis dubbed HerpeCide IntraOcular Injection and a formulation indicated for the treatment of ocular herpes keratitis, genital herpes, recurrent herpes labialis, herpes, chickenpox, PHN and shingles, dubbed HerpeCide Dermal Topical and Eye Drops. In addition to this, it is also engaged in HerpeCide program expansion drug projects for various herpes viruses; and researching and developing other nanoviricides for treating different indications and viruses.

The firm recently entered into an agreement with TheraCour Pharma Inc. to target encephalitis, conjunctivitis, dengue and Ebola. The development of cures for these ailments, which presently have no cures, will not only significantly boost the growth of both companies but also improve share prices and encourage more investments into the companies.

NanoViricides (NNVC), closed Tuesday's trading session at $1.46, up 23.8548%, on 182,054 volume. The average volume for the last 3 months is 17.836M and the stock's 52-week low/high is $1.04/$3.88.

InflaRx N.V. (IFRX)

MarketClub Analysis, TradersPro, MarketBeat, BUYINS.NET, StockMarketWatch, QualityStocks, InvestorPlace, Trades Of The Day, StreetInsider, Schaeffer's, Daily Trade Alert, The Stock Dork and Stock Market Watch reported earlier on InflaRx N.V. (IFRX), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

InflaRx N.V. (NASDAQ: IFRX) is a clinical-stage biopharmaceutical firm that is focused on the discovery and development of inhibitors through the use of C5a technology.

The firm has its headquarters in Jena, Germany and was incorporated in December 2007 by Nicolas Fulpius, Renfeng Guo and Niels Christoph Riedemann. Prior to its name change in 2017, the firm was known as Fireman BV. The firm is a holding company for InflaRx GmbH.

The company is party to a co-development agreement with Beijing Defengrei Biotechnology Company Ltd. It serves consumers around the globe, with a focus on the United States and Germany.

The enterprise’s product portfolio comprises of an IV delivered anti-C5a monoclonal antibody dubbed IFX-1, which has concluded its phase 2b clinical trial evaluating its effectiveness in treating hidradenitis suppurativa. This is a chronic and rare debilitating systemic inflammatory skin illness. The formulation has also been developed to treat another chronic inflammatory skin disease known as pyoderma gangrenosum, oncological ailments and another life-threatening and rare autoimmune illness known as ANCA-associated vasculitis. Its C5a inhibitor is an inflammatory mediator that helps improve various autoimmune and other inflammatory ailments. The enterprise is also involved in the development of IFX-2, which is in the pre-clinical development stage and has been designed to treat chronic autoimmune and inflammatory ailments.

The company recently released data from the open-label study of the effectiveness of its IFX-1 formulation in treating pyoderma gangraenosum. The success and approval of this formulation, which was well tolerated among patients, will bring in more investors into the company and boost its growth.

InflaRx N.V. (IFRX), closed Tuesday's trading session at $3.77, up 83.9024%, on 17,836,076 volume. The average volume for the last 3 months is 188,655 and the stock's 52-week low/high is $0.7762/$3.9299.

Rafael Holdings (RFL)

TradersPro, StreetInsider, Trading Concepts, QualityStocks and InvestorPlace reported earlier on Rafael Holdings (RFL), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Rafael Holdings Inc. (NYSE: RFL) is a holding firm that holds interests in early stage and clinical pharmaceutical firms as well as commercial real estate assets.

The firm has its headquarters in Newark, New Jersey and was incorporated in 2017. The firm has thirty-seven companies in its corporate family and serves consumers in the United States and Israel.

The company operates through the Pharmaceuticals and Real Estate segments. The pharmaceuticals segment consists of a majority equity interest in Farber, Levco, Barer and LipoMedix Pharmaceuticals and warrants and debt interests in Rafael Pharmaceuticals. The real estate segment refers to its real estate holdings, which include a building which houses the headquarters of the company. Under this segment, the company operates as part of the lessors of real estate industry.

The enterprise’s lead candidate is a formulation dubbed devimistat (CPI-613), which is being assessed in different clinical studies, including two phase 3 clinical trials for the treatment of refractory/relapsed acute myeloid leukemia and metastatic pancreatic cancer. It is also engaged in developing and commercializing therapies that exploit the metabolic differences between cancer cells and normal cells. It is involved in leasing commercial office buildings, as well as an 800-car public garage.

The company is committed to addressing unmet patient needs and furthering its research and development in cancer metabolism for the treatment of cancers like pancreatic cancer which are hard-to-treat, by bringing invaluable expertise into its fold, which can accelerate its ability to develop cancer therapeutics that improve and extend patient lives.

Rafael Holdings (RFL), closed Tuesday's trading session at $1.93, up 17.6829%, on 188,803 volume. The average volume for the last 3 months is 40.483M and the stock's 52-week low/high is $1.55/$2.85.

Butterfly Network (BFLY)

MarketBeat, The Street, StreetInsider, Schaeffer's, DrStockPick, FeedBlitz,,,,, Inside Investing Daily, InvestorPlace, Daily Trade Alert,, Trades Of The Day,, OTCReporter, QualityStocks,, The Online Investor, Top Pros' Top Picks and reported earlier on Butterfly Network (BFLY), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Butterfly Network Inc. (NYSE: BFLY) is an innovative digital health firm that is focused on the development, manufacture and commercialization of ultrasound imaging solutions.

The firm has its headquarters in Guilford, Connecticut and was incorporated in 2011, on January 25th by Jonathan M. Rothberg. Prior to its name change, the firm was known as Longview Acquisition Corp. It operates as part of the scientific research and development services industry, under the healthcare sector. The firm has seven companies in its corporate family and serves consumers internationally, with a focus on the United States.

The company’s objective is to transform non-invasive surgery and medical imaging by leveraging advances in cloud computing, deep learning and semiconductors. It is focused on democratizing medical imaging by making it accessible to every individual across the globe and contributing to the aspiration of international health equity.

The enterprise’s products are comprised of both software and hardware solutions which have been designed to make ultrasound imaging accessible to all healthcare practitioners including midwives, nurses and patients. These products include a handheld whole body ultrasound system known as Butterfly iQ; and an ultrasound imaging device dubbed the Butterfly iQ+ which has been designed to connect with a tablet or smart phone. These products are commercially available on the enterprise’s eCommerce website as well as in about twenty countries.

The firm recently announced its latest financial results for 2021 which show increases in revenues. It is focused on bringing new innovative solutions to market and implementing its growth strategy.

Butterfly Network (BFLY), closed Tuesday's trading session at $2.27, up 21.3904%, on 40,668,799 volume. The average volume for the last 3 months is 4,200 and the stock's 52-week low/high is $1.625/$8.72.

Imperial Metals (IPMLF)

StreetInsider and StreetAuthority Daily reported earlier on Imperial Metals (IPMLF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Imperial Metals Corporation (OTC: IPMLF) (TSE: III) (FRA: L7D) is a mining firm that is engaged in exploring for, developing and producing base and precious metals from Canadian mineral properties.

The firm has its headquarters in Vancouver, Canada and was incorporated in 1959. It operates as part of the copper industry, under the basic materials sector. The firm serves consumers around the globe.

The company operates through four segments, which include Red Chris, Mount Polley, Huckleberry, and Corporate. The Corporate segment includes all other properties and related exploration and development activities.

The enterprise’s holdings include the Mount Polley mine (100% owned), the Huckleberry copper mine (100% owned), and the Red Chris mine (30% owned). Its principal product is copper concentrate, which contains copper, gold, and silver. It also holds a portfolio of 23 greenfield exploration properties in British Columbia. Its Red Chris mine is located in northwest British Columbia, 80 kilometers south of Dease Lake. The property comprises of approximately 77 mineral tenures covering approximately 23,142 hectares. Mount Polley is an open pit copper/gold mine located in south-central British Columbia, 56 km northeast of Williams Lake, and covers approximately 20,113 ha comprised of seven mining leases and 46 mineral claims. Its Huckleberry copper mine is located 88 km from Houston, British Columbia, and covers an area of 23,241 ha, comprising of two mining leases covering 2,422 hectares, and 44 mineral claims.

The firm recently announced its latest financial results, which show increases in its revenues. It remains focused on generating additional value for its shareholders.

Imperial Metals (IPMLF), closed Tuesday's trading session at $1.49, off by 1.1281%, on 4,200 volume. The average volume for the last 3 months is 11,098 and the stock's 52-week low/high is $1.1951/$3.14.

Kiwi Property Group (KWIPF)

We reported earlier on Kiwi Property Group (KWIPF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Kiwi Property Group Ltd (OTC: KWIPF) (NZE: KPG) is a property investment firm that is focused on investing in, managing and developing a portfolio of diversified properties throughout New Zealand.

The firm was incorporated in 1992, on March 31st by Richard John Didsbury and is headquartered in Auckland, New Zealand. It operates through the Mixed-use, Office and Other segments. The firm generates maximum revenue from the Mixed-use segment.

The enterprise’s objective is to provide investors with an investment in New Zealand property, focusing on risk-adjusted returns over time through the ownership and management of a diversified portfolio. It is focused on maintaining a property investment portfolio comprising mixed-use properties, which includes regional shopping centers and large format retail within and outside Auckland region, and an office portfolio that includes office properties with floorplate, services, ideal location and car parking in Auckland, and government departments. The enterprise’s portfolio includes properties, such as Sylvia Park Lifestyle, LynnMall, Vero Center, ASB North Wharf, Sylvia Park, The Base, The Aurora Center and 44 The Terrace, among others. Its property portfolio is spread across Auckland, Hamilton and Wellington. The enterprise is the highest rated New Zealand company within CDP (Carbon Disclosure Project) and is a member of FTSE4 Good, a series of benchmark and tradable indices for ESG (Environmental, Social and Governance) investors. It is licensed under the Real Estate Agents Act 2008.

The company remains focused on generating value for its shareholders and bolstering its overall growth.

Kiwi Property Group (KWIPF), closed Tuesday's trading session at $0.5394, even for the day. The average volume for the last 3 months is 718,765 and the stock's 52-week low/high is $0.4683/$0.72615.

GeneDx Holdings (WGS)

We reported earlier on GeneDx Holdings (WGS), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

GeneDx Holdings Corp (NASDAQ: WGS) is a patient centered health intelligence firm that is engaged in the provision of genomics-related diagnostic and information services.

The firm has its headquarters in Stamford, Connecticut and was incorporated in October 2015 by Eric Schadt. Prior to its name change, the firm was known as Sema4 Holdings Corp. It operates as part of the health information services industry, under the healthcare sector. The firm primarily serves consumers in the United States.

The company focuses on AI and machine learning to leverage multidimensional, longitudinal, clinical, and genomic data to build dynamic models of human health and individualized health trajectories. Through its Centrellis health intelligence platform, it generates a more complete understanding of disease and wellness and provides science-driven solutions to the most pressing medical needs.

The enterprise’s health information platform, Centrellis, integrates digital tools with artificial intelligence to ingest and synthesize clinical and genomic data. Its products and services include Exome & genome testing, Test catalog and Genetic counseling. The enterprise provides 2 types of tests that examine a patient’s deoxyribonucleic acid (DNA), which include genome sequencing (GS/WGS) and exome sequencing (ES/WES). It offers tests for neurodevelopmental disorders, cardiology, oncology and others.

The company recently announced its latest financial results, with its CEO noting that they remained committed to delivering profitable growth and expanding into the adult and newborn screening markets. This will positively influence investments as well as the company’s overall growth.

GeneDx Holdings (WGS), closed Tuesday's trading session at $0.3301, off by 5.2254%, on 718,765 volume. The average volume for the last 3 months is 19,140 and the stock's 52-week low/high is $0.22/$3.125.

Elemental Altus Royalties (ELEMF)

We reported earlier on Elemental Altus Royalties (ELEMF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Elemental Altus Royalties Corp (OTCQX: ELEMF) (CVE: ELE) is a gold-focused royalty firm that is focused on acquiring and evaluating royalties.

The firm has its headquarters in Vancouver, Canada and was incorporated in 2004, on March 11th. It operates as part of the gold industry, under the basic materials sector. The firm serves consumers around the globe.

The company is focused on acquiring uncapped royalties and streams over producing, or near-producing, mines operated by established counterparties, as well as generating royalties on new discoveries.

The enterprise has 11 producing royalties and a diversified portfolio of pre-production and discovery stage assets. It is focused on acquiring uncapped royalties and streams over producing, or near-producing, mines operated by established counterparties, as well as generating royalties on new discoveries. The enterprise’s portfolio includes Karlawinda, Caserones, Wahgnion, Ming, Bonikro, Mercedes, Ballarat, Amancaya, South Kalgoorlie, Mt. Pleasant, Kwale and Pre-Production Royalties. The Bonikro open-pit gold mine is located in Cote d’Ivoire, approximately 230 kilometers northwest of Abidjan. The Caserones mine is situated in the Atacama region of Northern Chile. The Wahgnion mine is located southwest of Burkina Faso. The Karlawinda Gold Project is located in the Pilbara region of Western Australia, over 70 kilometers by road southeast of the town of Newman.

The company recently provided an update on its portfolio, with its CEO noting that they remained focused on expansion and diversification which would benefit its shareholders by increasing their exposure to multiple exploration programs simultaneously.

Elemental Altus Royalties (ELEMF), closed Tuesday's trading session at $1.08, up 6.9307%, on 19,140 volume. The average volume for the last 3 months is 10,399 and the stock's 52-week low/high is $0.7555/$1.265.

Urbana (URNAF)

We reported earlier on Urbana (URNAF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Urbana Corporation (OTC: URNAF) (TSE: URB) (CNSX: URB.A) is an investment fund launched and managed by Caldwell Investment Management Limited.

The firm has its headquarters in Toronto, Canada and was incorporated in 1947, on August 25th. Prior to its name change, the firm was known as Macho River Gold Mines Limited. It operates as part of the asset management industry, under the financial services sector. The firm serves consumers in Canada.

The company invests globally across the exchange sector, from cash markets to derivatives and from private, mutually owned exchanges, to those which are publicly traded. Its subsidiaries include Caldwell India Holdings Inc., Urbana Mauritius Inc., Urbana Special Investment Holdings Ltd., Urbana International Inc. and Radar Capital Inc.

The enterprise’s objectives are to seek out, and invest in private investment opportunities for capital appreciation and to invest in publicly traded securities. Urbana makes investments in a range of private companies across different industry sectors. Its investment portfolio includes private equity investments, public equity investments and private debt investments. It has owned resource properties in Urban Township, Quebec, where it holds approximately 44 claims in the area totaling over 1,154.4 hectares. Caldwell Investment Management Ltd. offers investment, portfolio management and other services to Urbana.

The company, which recently filed its latest financial results, was recently included on the Globe and Mail’s 2023 Report on Business magazine’s Women Lead Here list. It remains focused on executive gender parity and creating shareholder value.

Urbana (URNAF), closed Tuesday's trading session at $2.8622, up 1.4965%, on 10,399 volume. The average volume for the last 3 months is 36,461 and the stock's 52-week low/high is $2.71/$3.3312.

NextPlat Corp. (NXPL)

QualityStocks and The Stock Dork reported earlier on NextPlat Corp. (NXPL), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

NextPlat (NASDAQ: NXPL, NXPLW), a global e-commerce provider, today announced that it is launching the first in a series of new e-commerce development programs. According to the update, the programs are designed to assist businesses in expanding their existing online sales capabilities to reach new international customers in the Chinese market. “We are excited to launch the first in what we expect will be a series of e-commerce development programs next month here in Miami,” said Charles M. Fernandez, executive chairman and CEO of NextPlat. “These programs will allow us to directly engage and collaborate with other Florida-based businesses who wish to tap into the vast potential of global e-commerce. Together with our partners, we believe we can help local businesses of all kinds quickly grow their online revenues by tapping into millions of new international customers.”

To view the full press release, visit

About NextPlat Corp.

NextPlat is a global e-commerce platform company created to capitalize on multiple high-growth sectors and markets for physical and digital assets. The company intends to collaborate with businesses, optimizing their ability to sell their goods online, domestically and internationally, and enabling customers and partners to optimize their e-commerce presence and revenue. NextPlat currently operates an e-commerce communications services division through its Global Telesat Communications Ltd and Orbital Satcom Corp business units that offer voice, data, tracking, and IoT services to customers worldwide through multiple global storefronts.

NextPlat Corp. (NXPL), closed Tuesday's trading session at $1.75, up 9.375%, on 36,461 volume. The average volume for the last 3 months is 783,102 and the stock's 52-week low/high is $1.2115/$3.44.

Southern Copper Corporation (SCCO)

MarketBeat, SmarTrend Newsletters, InvestorPlace, The Street, Louis Navellier, The Online Investor, QualityStocks, Daily Wealth, Daily Trade Alert, TopStockAnalysts, The Wealth Report, Trades Of The Day, StreetAuthority Daily, Zacks,, Barchart, Money Morning, TheStockAdvisor, Early Bird, Kiplinger Today, Market Intelligence Center Alert, Schaeffer's, MarketClub Analysis, Top Pros' Top Picks, Market Authority, The Growth Stock Wire, Uncommon Wisdom, Investopedia, StreetInsider, TheStockAdvisors, ChartAdvisor, Market Report, Investment House, The Stock Enthusiast, Investiv, InvestmentHouse, Investing Futures, Greenbackers, Forbes, DrStockPick, Dividend Opportunities, CRWEWallStreet, CRWEPicks, CRWEFinance, Cabot Wealth, BestOtc, AllPennyStocks, DividendStocks, StockHotTips, Wealth Insider Alert, Wealth Daily, Vantage Wire, TradingMarkets, TradingAuthority Daily, The Tycoon Report, The Trading Report, The Motley Fool, Streetwise Reports, MarketDNA, StockLockandLoad, Investor Update, Profit Confidential, PennyToBuck, PennyOmega, Navellier Growth, Money and Markets, 24/7 Trader, InvestorsObserver Team, InvestorIntel, InvestorGuide and StockRockandRoll reported earlier on Southern Copper Corporation (SCCO), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Several major international copper producers have signed a memorandum of understanding (MoU) to create a more responsible and sustainable copper value chain. Two leading Chinese copper producers have partnered with Australia-based Broken Hill Proprietary (BHP) to help support the global transition to clean and renewable energy.

Copper will play a significant role in the energy transition as it is a key manufacturing component in several renewable energy technologies such as solar, wind, thermal and hydro-energy. It is also used to build electric vehicle motors and batteries due to its superior electrical conductivity, durability, reliability and malleability.

The MoUs between BHP, Daye Nonferrous and China Copper represent plans for increased collaborations between the companies to aid in the transition to green energy by strengthening the copper value chain and making it more sustainable. The agreements aim to give the respective companies a chance to use their expertise to help reduce the environmental impact of the copper value chain. These companies will also leverage their knowledge and experience to manage waste streams and improve energy efficiency and materials in the value chain. They will also be able to collaborate with downstream users and industry peers further down the line, as their collaboration is nonexclusive.

The companies hope this collaboration will help the copper industry develop more efficient innovations and technologies for mining, smelting and refining. Such technologies include byproduct recycling, lower-intensity reuse, low-carbon emission fuels and improved energy and heat efficiency. They may also brainstorm ways to improve value chain traceability and strengthen measurement, confirmation, and reporting.

With several countries across the globe looking to cut emissions as part of worldwide efforts to curb climate change, demand for metals such as copper is expected to soar. However, the world is currently dealing with a major copper shortage thanks to impacted supply streams and increased demand.

Robin Griffin, Wood Mackenzie vice president of metals and mining, predicts that the copper deficit will last till the end of the decade amid demand pressures and unrest in Peru that have dampened copper supplies. BHP chief commercial officer Vandita Pant also notes that demand for copper will “increase significantly” due to increased electrification and decarbonization. She said that as BHP continues supplying copper to the growing market, the company will strive to keep its operations as responsible and sustainable as possible.

The Australia-based company believes collaborating with Day Nonferrous and China Copper will accelerate efforts to create a sustainable and responsible copper value chain. As these major players in the copper value chain come together to conduct more sustainable operations, the ESG principles espoused by companies such as Southern Copper Corporation (NYSE: SCCO) will be brought to life on a larger scale.

Southern Copper Corporation (SCCO), closed Tuesday's trading session at $74.81, off by 3.146%, on 796,727 volume. The average volume for the last 3 months is 1.182M and the stock's 52-week low/high is $42.42/$79.315.

Atlis Motor Vehicles Inc. (AMV)

QualityStocks, Money Wealth Matters, GreenCarStocks, MarketBeat and 247 Market News reported earlier on Atlis Motor Vehicles Inc. (AMV), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

The profit for BYD increased by 446% to 16.6 billion yuan, or $2.4 billion, exceeding the company’s initial net earnings forecast that it had previously provided in January. In 2021, BYD reported 3 billion yuan, equivalent to 436 million dollars, in profit. The top EV producer in China said that it sold a significant number of vehicles in the past calendar year, which increased business earnings.

BYD, owned in part by Warren Buffet, is one of the companies best positioned to benefit from China’s expanding electric vehicle industry. After winning domestically, the company is now aiming to compete on the world stage with the likes of Tesla, the largest electric vehicle producer.

In 2022, BYD’s EVs and PHEVs sales numbered 1.86 million, one-half of which were BEVs alone. This accounts for approximately one-third of the total sales of Chinese nontraditional energy automobiles. Tesla, on the other hand, sold 1.31 million electric vehicle during the same year.

BYD wants to grow internationally, particularly in the United States as well as in Europe. Moreover, it plans to introduce two newly minted brands of high-end electric vehicles in the year, reversing course from the cost-effective products that have essentially contributed to its quick expansion.

The new high-end electric vehicles will support BYD’s continued revenue growth. However, a price competition that has been raging in China as a result of Tesla making price reductions towards its domestically produced models is anticipated to compress margins.

Near the end of last year, Tesla drastically reduced pricing for its vehicles in China in an effort to undercut local rivals. A second price cut on automobiles made at its factory based in Shanghai was announced in January 2023. As a result, Tesla vehicles produced locally are nearly 50% less costly than those sold in America and remain 14% cheaper year-over-year.

According to a Bloomberg story, at least 30 local and international manufacturers of electric vehicles were compelled to lower their costs in order to match the Tesla price cuts. Whereas Ford’s Mustang Mach-E is currently one-third less expensive compared to its price in the United States, certain manufacturers in China, such as Nio and Xpeng, gave discounts of up to 70,000 yuan, equivalent to $10,000.

In reaction, the Chinese Vehicle Manufacturers Association demanded a halt to the sales and warned that care must be taken to put a stop to such activities from degenerating into pricing wars in its report published by the state media in China. This call may be too little, too late, however, given that different EV makers are gearing up for a price war. It may now be up to startups such as Atlis Motor Vehicles Inc. (NASDAQ: AMV) to find suitable ways to remain competitive in the years to come.

Atlis Motor Vehicles Inc. (AMV), closed Tuesday's trading session at $0.5056, off by 6.3704%, on 1,304,341 volume. The average volume for the last 3 months is 973 and the stock's 52-week low/high is $0.50/$243.99.

The QualityStocks Company Corner

Fintech Ecosystem Development Corp. (NASDAQ: FEXD)

The QualityStocks Daily Newsletter would like to spotlight Progressive Care Inc. (OTCQB: FEXD).

The FEXD management team has extensive international experience indeveloping global fintech platforms and services

The company in September 2022 announced a business combination withRana Financial, which provides transfer of funds services betweenthe U.S. and Latin America

At that same time, FEXD announced the acquisition of Afinoz, adigital lending platform used by India’s leading banks

In January 2023 the company announced an extension to close itsannounced business combinations with Rana and Afinoz through April2023

Fintech Ecosystem Development Corp. (NASDAQ: FEXD) is a special purpose acquisition company (SPAC) formed for the purpose of effecting one or more business combinations with an intent to focus on the financial technology sector.

The company’s mission is to create and grow a global financial services ecosystem to address unmet mobile money needs in developing and industrialized countries and markets. FEXD plans to achieve this by acquiring and merging with financial technology pioneers that have the potential to help establish its global fintech ecosystem, and by continuing the development of proprietary technologies and applications to keep the company at the forefront of the cashless society market.

Digital money is replacing physical cash. Consumers can buy products and services from anywhere in the world and make payments across borders. Parents can send money to students studying in other countries. Migrant workers are sending money to families in developing nations. Rural villagers without banks can send and receive money using their smartphones. FEXD is developing mobile transaction platforms, applications and services that are helping to implement these changes.

The company plans to offer a diverse portfolio of products and services to consumers and businesses in the United States, South Asia, East Asia, Africa, Europe and Latin America. Its growth strategy includes acquisition, innovation and market development.

FEXD is a Delaware corporation based in Collegeville, Pennsylvania. The company was launched in May 2021 by a management team led by Dr. Saiful Khandaker that has extensive experience in developing and managing financial service platforms and applications, primarily in the mobile money sector. FEXD is sponsored by Revofast LLC.

Acquisition Targets

In September 2022, FEXD announced definitive agreements for business combinations with Rana Financial Inc., a Georgia corporation, and Mobitech International LLC (dba Afinoz), a limited liability company organized in the United Arab Emirates. The agreements call for Rana and Afinoz to become wholly owned subsidiaries of FEXD, with the combined company expected to continue trading on the Nasdaq under existing ticker symbol ‘FEXD’. The mergers are expected to close in Q2 2023.

Rana Financial

Rana Financial is a licensed money transfer company founded in 2009. Rana provides fast and affordable online and mobile transfer of funds between the U.S. and Latin America. Rana has been providing money transfer services in the U.S. market for 13 years and has 30,000 active users. Rana’s money transfer business grew to 200,000 transactions in 2021. The merger agreement values Rana at an implied $78 million enterprise value.

Mobitech International LLC

Mobitech International LLC (dba Afinoz) is an artificial intelligence-enabled digital lending platform used by India’s leading banks, non-banking financial companies and fintech loan providers. Afinoz’s fintech platform supports enterprises making loans primarily to middle- and working-class borrowers via its website or through its mobile phone application. Afinoz’s platform makes loans available and affordable to millions of Indian workers and unbanked users by providing access at a low cost. Afinoz’s platform has more than 50 lending partners, and its database of registered users in India includes more than two million individuals. The merger agreement values Afinoz at an implied $120 million enterprise value.

Market Opportunity

According to analysis by global market research firm Mordor Intelligence, the worldwide financial technology market is valued at approximately $194 billion in 2023 and is projected to grow to nearly $500 billion by 2028, representing a CAGR of 18.97% for the forecast period. According to the report, various financial crises and the COVID-19 pandemic have fueled consumer adoption of, and investor interest in, fintech over the past several years.

Management Team

Dr. Saiful Khandaker is Founder, CEO and President of FEXD. He is Group CEO and founder of FAMA Holdings Inc., a global developer of fintech platforms, applications and services based in the U.S. with offices in the U.K., India, Bangladesh and Zambia. He is currently leading the development of the FAMACASH™ network, a global fintech ecosystem to provide fast, affordable mobile money services in underserved countries such as Bangladesh. Before founding FAMA, Dr. Khandaker spent more than two decades leading the development of software solutions for Fortune 100 companies and startups. He also helped numerous clients modernize their fintech services as Chief Technology Officer at Mi3. He holds a Doctor of Management in Organizational Leadership, a Master of Science in Technology Management, and a Bachelor of Science in Computer Information Systems.

Jenny Junkeer is CFO at FEXD. She is a Chartered Accountant with over 17 years of experience. As CEO of Junkeer New Era Consulting, she leads a team specializing in helping companies launch and optimize business operations in fast-changing industries. She has extensive experience helping organizations scale operations to maximize value. She is an Adjunct Association Professor at Deakin University in Australia, a board member of the Global Health Initiative Foundation, and Director of Implementation at ConnectCV. She holds a Bachelor of Commerce Degree (Honors) from Monash University.

FingerMotion Inc. (FEXD), closed Tuesday's trading session at $10.59, up 0.046291%, on 1,231 volume. The average volume for the last 3 months is 7,186 and the stock's 52-week low/high is $9.94/$11.00.

Recent News

Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF)

The QualityStocks Daily Newsletter would like to spotlight Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF).

Ucore announced new additions to its executive and management teamsin what the Chairman and CEO, Pat Ryan, believes strengthens andadvances the company’s fundamental corporate tenet

Geoff Atkins was appointed as Ucore’s Vice President of BusinessDevelopment, while Jaan Hurditch was appointed as EngineeringDirector, leading the company’s engineering activities

Ucore also bolstered its Advisory Board with the appointment of Dr.Ahmad Hussein, who will also serve as the Government Liaison

These appointments come just in time following the commissioning ofthe demonstration plan in Kingston, Ontario

Ucore Rare Metals (TSX.V: UCU) (OTCQX: UURAF), a critical metals (“CM”) separation technology company, justannounced new additions to its executive and management teams in amove that sees the company transition toward production. As acompany committed to executing an environmental, social, andgovernance (“ESG”)-centered plan toward establishing acomprehensive North American critical metals supply chain, theseappointments, according to the company’s Chairman and CEO, PatRyan, allow Ucore to strengthen and advance its fundamentalcorporate tenet (

Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) is engaged in Rare Earth Element (REE) resource development and in commercializing its critical metals separation technology, RapidSX™, for the mining and metals extraction industry. The company is guided by principles of environmental, social and corporate governance (ESG) with a focus on disrupting China’s current dominance of the U.S. REE supply chain.

Ucore’s vision is to become a leading advanced technology company providing best-in-class metal separation products and services to the mining and mineral extraction industry. It plans to aid in the development, through strategic partnerships, of a North American REE supply chain controlled by the U.S. and its allies.

The company intends to contribute to this initiative through the near-term development of a heavy and light rare-earth processing facility in Louisiana and subsequent development of Strategic Metals Complexes (SMCs) in Alaska and Canada, as well as through the longer-term development of its 100%-owned Heavy Rare Earth Element (HREE) mineral resource property at Bokan Mountain on Prince of Wales Island, Alaska.

Ucore is headquartered in Halifax, Nova Scotia.

Projects & Technology

RapidSX™ Demonstration Plant

The Kingston, Ontario, RapidSX™ Demonstration Plant commissioning process is underway. Once commissioned, the plant is designed to demonstrate the commercial capabilities of the RapidSX technology platform.

The RapidSX demo plant will show:

  • The techno-economic advantages of the RapidSX technology platform
  • The processing of tens of tons of heavy and light mixed rare earth element concentrates in a simulated production environment
  • The platform’s ability to operate for thousands of semi-continuous run-time hours
  • Production of high-purity NdPr, praseodymium, neodymium, terbium and dysprosium rare earth elements for early OEM product qualification trials

The demo plant is located within Ucore’s 5,000-square-foot RapidSX Commercialization and Demonstration Facility and is run by its laboratory partner, Kingston Process Metallurgy Inc. (“KPM”).

RapidSX™ Technology

Innovation Metals Corp., acquired by the company in 2020, developed the RapidSX separation technology platform with early-stage assistance from the United States Department of Defense, later resulting in the production of commercial-grade, separated rare earth elements at pilot scale.

RapidSX combines the time-proven chemistry of conventional solvent extraction (SX) with a new column-based platform that significantly reduces time to completion and plant footprint, as well as potentially lowering capital and operating costs. SX is the international REE industry’s standard commercial separation technology and is currently used by all REE producers worldwide for bulk commercial separation of both heavy and light REEs.

Utilizing similar chemistry to conventional SX, RapidSX is not a “new” technology, but it represents a significant improvement on the well-established, well-understood, proven conventional SX separation technology preferred by REE producers.

Strategic Metals Complex

Ucore, engineering partner Mech-Chem Associates Inc. and KPM are developing the full-scale engineering for the company’s first Strategic Metals Complex (SMC). The SMC is a planned REE separation and rare earth oxide production plant slated to commence construction in Louisiana in 2023. It is scheduled to initially process 2,000 tons of total rare earth oxides by the end of 2024, increasing to 5,000 tons in 2026.

Bokan-Dotson Ridge REE Deposit

Ucore has invested over C$35 million to establish and validate the Bokan-Dotson Ridge resource in preparation for mine design and permitting. Initial drilling is complete, and a Preliminary Economic Assessment has been issued. Next steps for the project include a feasibility study, detailed mine design and permit acquisition. The project can be “near shovel ready” for construction in less than 30 months after receipt of the next stage of development funding.

Market Opportunity

According to a report by Grand View Research, the global rare earth elements market was valued at $2.8 billion in 2018 and is forecast to reach a value of $5.6 billion by 2025, achieving a CAGR of 10.4% during the period. Market growth is driven by increasing demand for these elements in the manufacturing of magnets and catalysts for the automotive industry. Rising demand for electric vehicles to reduce CO2 emissions is expected to propel the use of permanent magnets in the production of EV batteries.

China is the major producer and consumer of REEs. To maintain self-sufficiency and to meet future demand, China has been raising the export tariffs on rare earth elements shipped to various countries, including the U.S., Japan, India, Brazil and the European Union. This led to the current supply-demand gap in these countries, as they rely on imports from China.

China reduced the exports of REEs by 72% in the second half of 2010 to preserve its reserves of these elements and continues to export REEs at reduced levels, thereby affecting industries such as automotive, oil and gas, and electronics, which require an ample amount of rare earth elements.

Management Team

Pat Ryan, P.Eng., is Chairman and CEO of Ucore Rare Metals. He began as a director with the company when he developed a heightened interest in critical metals. Before joining Ucore, he founded and led a multimillion-dollar automotive OEM design and lean manufacturing company. His understanding of complex supply chains across international markets has led to a prime positioning as the global auto industry transitions to vehicle electrification. He holds a Bachelor of Engineering degree from Dalhousie University.

Peter Manuel is Vice President and CFO of Ucore. Prior to joining the company, he practiced as a Chartered Accountant for more than 17 years, providing consulting services to companies in a range of industries, with a focus on the financial services and resource sectors. He spent 10 years in England and Ireland providing assurance, strategic planning, corporate finance and other consulting services to a portfolio of both public and private entities. He holds a Bachelor of Commerce Degree from Dalhousie University.

Michael Schrider, MEng, P.E., is Vice President and COO of Ucore. He is a multidisciplinary engineer who has been involved in manufacturing, engineering and managing complex structural and mechanical systems projects since 1989. He was the Founder, President and Chief Engineer of Schrider & Associates and Alton Bay Design, both engineering services firms. He holds a bachelor’s degree in naval architecture and marine engineering from the University of New Orleans and a master’s degree in mining, geological and geophysical engineering from the University of Arizona.

Mark MacDonald is Vice President of Investor Relations at Ucore. He has over 25 years of experience implementing award winning business development and marketing programs at regional and national levels. As Vice President of Sales, he was responsible for Mediapro Communication’s growth as AT&T Canada’s leading B2B sales partner. He subsequently became Atlantic Regional Vice President of AT&T Canada Corp. He holds a Bachelor of Commerce degree from Dalhousie University.

Ucore Rare Metals Inc. (UURAF), closed Tuesday's trading session at $0.89, up 1.1364%, on 7,186 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $11.00/$.

Recent News

Battery Mineral Resources Corp. (TSX.V: BMR) (OTCQB: BTRMF)

The QualityStocks Daily Newsletter would like to spotlight Ucore Rare Metals Inc. (TSX.V: BMR) (OTCQB: BTRMF).

Battery Mineral Resources (TSX.V: BMR) (OTCQB: BTRMF) is providing an update on its ESG initiatives, including its workwith Integratio Mediação Social e Sustentabilidade, which hasresulted in the completion of a policy, strategy and implementationguide for current and future social and community engagement andreporting. In addition, the company announced it is granting atotal of 2,330,000 Performance Share Units (“PSUs”) to 13management personnel, officers, and directors. “The allocation ofincentive shares is in alignment of BMR’s mission to maintain andenhance our positive and productive relationship with shareholderswhile accordingly incentivizing our management and board who areunilaterally working towards positioning BMR into cash flowing viathe resumption of operations at our Punitaqui copper mine inChile,” said Battery Mineral Resources CEO Martin Kostuik in thepress release. “In addition, we are proud to update our investorsregarding our achievements to develop productive, ethical andtransparent relationships with our surrounding communities. It isour duty to our shareholders, employees and communities to promotesustainable growth supported by safe and socially responsiblebusiness practices while developing long-term resources. We lookforward to progressing advancement of our relationships with thepeople of the communities of Potrerillos and Punitaqui as wecontinue working diligently to restart our Punitaqui copper mine inthe coming months of 2023.”

To view the full press release, visit

Battery Mineral Resources Corp. (TSX.V: BMR) (OTCQB: BTRMF) is a battery minerals company providing shareholders exposure to the global mega-trend of electrification while being focused on growth through cash-flow, exploration and acquisitions in favorable mining jurisdictions.

The company’s mission is the discovery, acquisition and development of battery metals (namely copper, cobalt, lithium, and graphite) in North America, South America and South Korea. It aims to become a leading low-cost producer of high quality, ethically sourced battery metals from high-grade, low impact mines in stable jurisdictions that are close to major consumer industries.

BMR is headquartered in Vancouver, British Colombia, with a portfolio of projects spanning Canada, the U.S., Chile and South Korea.

Project Portfolio

BMR’s current focus is the restart of its Punitaqui copper mine in Chile, as well as the exploration and development of its cobalt, lithium and graphite assets in North America and South Korea. The company also continues to identify and evaluate new project opportunities in its operating jurisdictions.

Its current portfolio includes:

Chile – Copper

BMR’s 100%-owned Punitaqui copper mine, acquired in March 2021, has the potential to generate an annual EBITDA of up to $50 million at or above a copper price of $4.25/lb. The company’s flagship project, the Punitaqui mine has been the subject of numerous milestones in recent months, including:

  • BMR funded and completed a successful 32,526m resource drill program in 2022. Metallurgical testwork has confirmed the ability to produce excellent copper concentrates from each of the five zones tested, including recoveries ranging from 81% on the low end at Cinabrio Norte up to 96.5% at the Dalmacia deposit.
  • The company in August 2022 reported the results of its first ever NI 43-101-compliant resource estimate for the underground deposits at its Punitaqui copper mining complex of 6.2 million tonnes grading 1.14% Cu in indicated category, along with 3.1 million tonnes grading 0.93% Cu in the inferred category. This resource estimate greatly exceeded management goals.
  • In September 2022, BMR announced the approval by the Chilean Environment Assessment Service for the Environmental Impact Declaration (“DIA”) pertaining to mining at the company’s Cinabrio mine and San Andres deposit. The approval of the DIA allows BMR to move forward with starting mining operations in 2023 and restarting the mill at its Punitaqui copper mining complex soon after.
  • BMR is focused on securing the final funding for the restart of mining and resumption of copper concentrate production at Punitaqui. Once this funding is received, BMR aims to complete mine rehabilitation and development in four to six months, with the ramp up from first production to the full production rate of 20-25 million pounds of copper in concentrate per annum to require a further four to six months.

“From exploration, engineering, community and permitting successes to realizing several non-dilutive means of funding to allow BMR to advance the project, our team looks forward to taking advantage of the renewed positive market sentiment for near term copper pricing and placing ourselves in a strong position to participate in a robust copper sector in 2023,” CEO Martin Kostuik stated in a news release.

Canada – Cobalt/Silver

Between 2016 and April 2018, BMR acquired through claim staking, option, joint venture and direct purchase the largest regional land holding in the historic home of high-grade cobalt-silver veins in Canada known locally as the Cobalt Embayment.

As of February 2023, BMR controlled a land package totaling 9 properties with 4,086 tenements that encompass an area of 84,003.39Ha. The key projects within the land package include McAra, Gowganda, Elk Lake, Fabre and Wilder. From 2017-2022, a total of 412 holes/51,452.34m were drilled on eight projects/20 targets. In addition, a total of 26,709 Line-Km of airborne geophysical surveys & 1,324.84sqkm of LiDAR topography was flown. Follow-up ground geophysical surveys resulted in a total of 37 surveys (514.64 Line-Km) being completed.

Initial NI 43-101 compliant resource defined at McAra (M&I Resource of 1,124,000lbs Co) was detailed in a Technical Report on Cobalt Exploration Assets in Canada dated as of February 5, 2021, with an effective date of October 31, 2020, prepared by SRK Consulting – G Cole PGeo (APGO#1416).

Idaho – Cobalt

BMR holds the Bonanza and East Fork properties located in the historic cobalt-copper-gold Blackbird mining district (Blackbird Mine from 1902-1963 produced 17Mt grading 0.7% Co, 1.4% Cu, and 1 g/t Au) located about 30 kilometers west of Salmon, Idaho. The Bonanza project is immediately adjacent to Jervois Global’s Idaho Cobalt Operations, the United States’ only operating primary cobalt mine. At Bonanza, there are seven mineralized sites within an area over three kilometers wide that extends along a gabbro dyke striking continuously for over six kilometers northward from Noranda’s historic Blackbird Cobalt/Copper mine. The showings on the project are Bonanza Copper Tunnels, Tinker’s Pride, Bonanza Copper #25, Indian Creek, Gray Copper, Blackrock #4 and Papoose #’s 1-4.

From 2018-2021, BMR’s Bonanza Exploration included 550 line-km of airborne magnetics and radiometrics followed up by surface exploration that included rock sampling, soil sampling, channel sampling of historic workings and 3.6km of time domain induced polarization geophysics.

The two properties cover 12 significant cobalt-copper prospects within the known mineralized zone. Both of the BMR Idaho cobalt belt properties host excellent high-grade discovery potential.

South Korea – Graphite

BMR has 100% ownership of the Guemam and Taehwa graphite exploration projects containing high-purity flake graphite deposits. Both assets are past-producing mines with existing local infrastructure and near-term production potential.

Nevada – Lithium

The company’s Amargosa lithium project is in the southern Basin & Range province and central Mojave Desert of Nevada. It is an early-stage exploration opportunity in a favorable region that hosts numerous lithium occurrences, including the Clayton Valley lithium deposit owned by Cypress Development Corp., as well as a major nearby lithium brine mine currently in production called the Silver Peak mine held by Albermarle Corp., one of the world’s largest lithium producers.

Market Opportunity

Near-term forecasts for the copper sector are extremely bullish, with stalwart Wall Street firms such as Goldman Sachs and Bank of America projecting record highs in the coming months. A combination of short-term supply deficits and long-term energy transition demand are expected to buck the downward pressures that have impacted copper prices in recent years.

Goldman in December 2022 forecast a 178K metric ton deficit in the copper market in 2023, causing the firm to raise its 12-month target to $11K/ton and its average price for calendar 2023 to $9,750/ton.

With China likely to continue accelerating efforts to restock depleted inventories in the wake of its COVID-19 reopening and a sustained push toward electrification around the globe placing a strain on supply, BMR is uniquely positioned to capitalize through the anticipated restart of operations at its Punitaqui copper mine.

Management Team

JMartin Kostuik is CEO and a Director of BMR. He brings to the company nearly three decades of diversified experience in the mining industry as a mining engineer and senior executive. Prior to joining BMR, Mr. Kostuik served as president and director of Arizona Gold Corporation and as CEO and director of Rupert Resources Limited. He built a broad base of experience in operations, engineering, exploration and capital projects with various companies including Luna Gold (Equinox), Barrick Gold Corporation, Taseko Mines Limited and DMC Mining Services. Mr. Kostuik earned his B.S. in Mining Engineering from Queen’s University and his M.B.A. from the University of Tennessee.

JMax Satel is the company’s CFO. He has over 18 years of experience as a successful natural resources-focused executive, most recently serving as EVP Corporate Development & Investor Relations for Arrow Exploration Corp., a TSX Venture- and AIM-listed oil & gas company with operations in Colombia and Canada. Prior to joining Arrow, Mr. Satel was principal and co-founder of Bordeaux Capital Inc., a Toronto-based advisory firm focused on the capital needs of companies across the natural resources sector, where he led and executed project financing advisory mandates involving global financial institutions and private equity funds. He earned a Bachelor of Commerce in Finance and Economics from the University of Toronto.

Jacob Willoughby is VP Corporate Development & Strategy for BMR. He brings to the company nearly 17 years of diversified experience in mining capital markets, including over eight years as a mining analyst covering exploration and development companies globally in both precious and base metals. Mr. Willoughby was most recently Vice President of Research and Analyst at Red Cloud Securities in Toronto. He spent two years as President and Director of Aldridge Minerals, a former Canadian based public exploration and development company with assets in Turkey and Papua New Guinea. Mr. Willoughby earned both a B.S. in Geology and a Masters in Business Administration from the University of Windsor.

FingerMotion Inc. (BTRMF), closed Tuesday's trading session at $0.14695, up 24.2181%, on 2,100 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.0355/$1.05.

Recent News

Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF)

The QualityStocks Daily Newsletter would like to spotlight Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF).

Delic Holdings (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), a leader in new medicines and treatments for a modern world, hassigned a letter of intent with Peter/PetraMD, the largest onlineprovider of hormone therapy in the United States for theacquisition of Ketamine Wellness Centers. According to theannouncement, the acquisition provides an incredible on-ramp intothe ketamine space for Peter/PetraMD, which has more than 20 yearsof experience and nearly 100,000 patients across the United States.Ketamine Wellness Centers is the largest ketamine infusion therapyprovider in the country. According to the announcement,Peter/PetraMD plans to maintain continuity of care for currentpatients while expanding into the national market. The LOI outlinesplans for PeterMD to pay $1.15 million in tranches over 12 monthsplus the assumed existing debt to buy the Ketamine WellnessCenters; the agreement is subject to a due-diligence period, thecompletion of a definitive agreement and a $100,000 nonrefundabledeposit. “I saw an incredible opportunity for Peter/PetraMD totruly expand the footprint and the success of ketamine treatmentnot only in our veteran population, but also at the nationallevel,” said Peter/PetraMD founder Dr. Bryan Henry in the pressrelease. “This is a chance for more of our veteran community tohave access to the care they desperately need.”

To view the full press release, visit

Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) is the leading psychedelic wellness platform, committed to bringing science-backed benefits to all and reframing the psychedelic conversation. The company owns and operates an umbrella of related businesses, including trusted media and e-commerce platforms like Reality Sandwich and Delic Radio; Delic Labs, the only licensed entity by Health Canada to exclusively focus on research and development of psilocybin vaporization technology; Meet Delic, the premiere psychedelic wellness event; and Ketamine Infusion Centers, one of the largest ketamine clinics in the country.

Delic is backed by a team of industry and cannabis veterans and a diverse network, whose mission is to provide education, research, high-quality products, and treatment options to the masses. Its founders helped build the multi-billion-dollar cannabis industry and aim to do the same in psychedelics as it follows a similar path toward legalization. In its quest to advance the new psychedelic renaissance upon us, Delic has become the pioneer in its field, creating an ecosystem of opportunities by investing in cutting-edge ideas.

The Vancouver-based company was formed in 2019 to address the growing interest in psychedelic wellness backed by science. Delic was the ‎first psychedelic umbrella platform. It is currently a trusted source for those interested in ‎psychedelic culture, education, treatments, and more.

While other emerging companies focus on patent medicine and big pharma for substances limited by government regulation, Delic is blazing a unique trail. It identifies ancillary and fully legal opportunities like IP, new media, live events, ketamine clinics (with the ability to offer additional psychedelic treatments once legalized, and large-scale production and brings them under its big tent of resources and reach.

The Big Problems Delic Is Addressing

  • Fifty percent of Americans will meet the criteria for a mental health condition sometime in their lifetime. The FDA has approved psilocybin therapy as a breakthrough therapy for depression.
  • Every 40 seconds, someone in the world commits suicide. Ketamine has been shown to decrease thoughts of suicide significantly. In 2019, the FDA approved esketamine as a fast-acting antidepressant.
  • Traditional palliative care methods do not eradicate end-of-life (EOL) anxiety. LSD and psilocybin have been shown to reduce EOL anxiety for terminally ill patients. Eighty percent of terminally ill patients with psilocybin sessions experienced significant reductions in depression and anxiety.
  • Approximately 50 million people in the U.S. are addicted to some tobacco product. Research shows that psilocybin is helping people quit smoking.

The Delic Ecosystem

The Delic Ecosystem covers three main areas: media, health, and science. The media focus is educating and motivating the masses through a variety of digital platforms, like Delic’s Reality Sandwich digital magazine, a free public education platform providing psychedelic guides, news and ‎culture (1.4+ million page views in 2020 and 54k social media followers across all platforms); Meet Delic, the first-ever psychedelic wellness summit and the premier psychedelic wellness event based in Las Vegas (over 2,000 live attendees and 5,000+ email subscribers); and Delic Radio (over 43 episodes and 100k total streams). Delic has also been featured in numerous media outlets like Forbes, NBC News, The Joe Rogan Experience, Daily Beast, High Times, and The Dr. Drew Podcast.

The focus of Delic’s health operations is the most accessible psychedelic treatments that can help billions of people live happier lives. Delic does this through one of the largest ketamine clinic chains in the country, Ketamine Infusion Centers (KICs), a limited liability corporation formed under the laws of Arizona that runs three ketamine clinics located in Bakersfield, California, and Phoenix, Arizona. Its management team has over 15 years of experience in the clinic and medical space, scaling and operating over 20 clinics, with a plan to open 10 more clinics in the next 18 months. Together, these clinics have overseen 4,000+ treatments delivered to date.

The focus of Delic’s science operations is developing IP and advanced extraction and testing facilities that are the backbone of the legal market. Delic carries this out through Delic Labs, a licensed cannabis and psilocybin research laboratory based in Vancouver. It’s the only entity licensed by Health Canada to exclusively focus on research and development of psilocybin vaporization technology.

Founded by award-winning chemists, Delic Labs focuses on extraction optimization, analytical testing, and chemical process development to advance the cannabis and psilocybin industries. Health Canada gave it a Section 56 Exemption to work with psilocybin compounds, allowing the company to possess and research these products for development and quality control before they hit the market.

Latest Acquisition – Homestead Book Company

On March 4, 2021, Delic announced its acquisition of Seattle-based Homestead Book Company. Homestead is a legacy counterculture distributor of psychedelic media. It’s also the creator of one of the first self-contained psilocybin mushroom grow kits.

The acquisition of Homestead is an exciting one, as it shows how Delic is increasing accessibility to this nascent industry within regulated jurisdictions. Homestead has sold tens of thousands of mushroom kits globally and was one of the earliest distributors for High Times and many other counterculture publications.

The Homestead acquisition allows Delic to increase its product offerings on its website, Reality Sandwich, which recently hit a record for average monthly traffic of over 200,000 unique visitors and over 2.6 million active readers in 2020.

Market Outlook

The psychedelic renaissance is here. Just in time to help address the global mental health crises, plant medicines have the potential to help billions of people live happier lives. Thanks to university-led and FDA-approved studies, North America is leading the way in advancing an industry as psychedelics are becoming accepted globally for therapeutic, medical, and recreational use. Here are some statistics:

  • 32 million people in the U.S. have used psychedelics at least once
  • 17% of all American adults between 21 and 64 have used psychedelics at least once
  • $500 billion is spent in the U.S. every year on prescription drugs
  • $238 billion is spent in the U.S. every year on mental health treatments and ancillary services
  • The anxiety disorder and depression treatment market is estimated at $16 billion
  • $187.8 billion was spent in 2013 on mental health and substance abuse disorders

Management Team

Delic Co-Founder and CCO Jackee Stang was an executive at High Times, a leading counterculture publication that became the voice for the cannabis industry. The monthly magazine had a circulation of over 500,000 copies per issue. Its website attracted 500,000 to five million users each month by 2014.

Likewise, company Co-Founder and CEO Matt Stang was a previous owner and operator of High Times, a position from which he played an instrumental in legalizing cannabis in multiple states and launched the Cannabis Cup in America. After interacting with the cannabis community for two decades, he helped found Delic in 2019 as one of the first psychedelic corporations. He shapes the company’s vision and path using his expertise in branding, marketing, business development, and product viability.

Delic’s VP of Business Development, John Coleman, Ph.D., is a former president of Anandia Labs, a biotech company focused on genetics and analytics. Having experience in both science and business, Dr. Coleman is well-equipped to lead Delic’s business development efforts as it strives to enter new vertical markets.

Zak Garcia is the company’s Chief Marketing Officer. He was the former CMO of Bulletproof Inc., maker of the well-known Bulletproof Coffee brand. Mr. Garcia is a marketing and leadership strategist who helped grow Bulletproof Coffee to over $250 million in revenue.

Delic Holdings Corp. (DELCF), closed Tuesday's trading session at $0.0073, up 46%, on 59,630 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.0031/$0.092105.

Recent News

GeoSolar Technologies Inc.

The QualityStocks Daily Newsletter would like to spotlight GeoSolar Technologies Inc.

Assurance released a new study ranking every state for 11sustainability factors ranging from solar power to electric heatand recycling regulations, with Oregon coming out on top

GeoSolar Technologies is an emerging leader in the space with itsnew Smart Green(TM) Home that includes a rooftop solar system,geothermal loops, EV charging station, and more

As measured by the HERS Index, a Smart Green(TM) Home isessentially 100% more efficient than a typical home built in 2006

Whether motivated by financial incentives, environmental concerns,or both, people are increasingly looking to climate and walletfriendly technologies in their homes. In a study published on March21, 2023, insurance company Assurance analyzed 11 environmentalranking factors to provide a clearer look at the green movement anddiscern which are the best locations for green homes. Green homesuse carbon-free technology like rooftop solar panels and electricheat pumps rather than those powered by fossil fuels. Forfull-service provider GeoSolar Technologies (“GST”), its Smart Green(TM) Home system takes decarbonizing ahome to the next level. A whole-house audit is followed byoptimizing insulation, designing, and installing a rooftop solarsystem for the home’s electricity, new electric vehicle chargingstation, backup battery power, upgraded windows, solar washer anddryer, smart LED lights, and new HVAC (heating, ventilation, airconditioning) system complete with geothermal piping, smart airfiltration, and electric heat pump.

GeoSolar Technologies Inc. (“GST”) is a Colorado-based climate technology company and the creator of the Smart Green Home® system for newly built and existing residences and commercial buildings. The company is focused on revolutionizing the way we heat, cool and power homes with 100% natural energy sources. Its patent-pending integrated system harnesses energy from the earth and sun to power and purify homes and automobiles without the use of fossil fuels.

In a GST home, the sun’s energy is captured on the roof to generate all of the electricity required. Additionally, the consistent climate of the earth is used to keep the home at a perfect temperature year-round, and the company’s proprietary air purifying unit ensures that the air inside the home is safe and healthy.

GST’s home technology has been installed in multiple test homes in Colorado and achieved exceptional results, including some of the most impressive energy efficiency ratings (HERS) in the industry.

GeoSolar Technologies is currently accepting investment as part of a Regulation A+ offering. Everyone* can invest now for as little as $300. For more information, visit the company’s profile on Manhattan Street Capital and review its Offering Circular.

GeoSolar Technologies Inc. (“GST”) has been qualified by the U.S. Securities and Exchange Commission (SEC) to conduct a Regulation A+ capital raise. GST is already a publicly traded company who makes quarterly and annual filings with the SEC and is subject to quarterly PCAOB audits. This is the first time shares of GeoSolar Technologies are being made available for public purchase. Upon completion of this Regulation A+ offering, the company intends to seek a listing of its stock.


The Decarbonization Movement

Soaring and unstable energy/fuel costs continue to highlight the importance of rethinking the traditional approach to powering homes, from top to bottom. While most everyone is well aware of the remarkable, multi-trillion-dollar opportunity the electric vehicle transformation offers to investors (in addition to the benefits to the climate problem), few recognize that the all-electric home market is as large as electric vehicles and equally important to reducing carbon emissions.

U.S. energy expenditures clocked in at $3,891 per person in 2018, leading to estimated spending of $1.3 trillion on energy that year alone. Despite this, fewer than 3% of U.S. homes are currently powered by solar. This number is poised to increase exponentially as both new and existing residences transition to zero carbon models.

GST estimates that if all the homes in America were powered by its technology, carbon pollution could be reduced by an estimated 1.9 trillion pounds per year, greatly reducing the negative impacts on our climate.


The GeoSolarPlus (“GSP”) system combines solar power, geothermal ground-sourced energy and other clean energy technologies into one fully integrated system.
Key benefits of the GSP system include:

  • Making a real planet-changing difference in reducing air pollution
  • Eliminating or significantly reducing homeowners’ future utility bills
  • Enjoying lifetime energy independence and protection from price escalation and energy shortages
  • Eliminating greenhouse gas emissions from operation of home and daily life
  • Increasing home value
  • An integrated design for seamless operation of renewable energy systems
  • Maintaining a significantly healthier living environment
  • Leveraging existing renewable energy tax credits and electrification incentives
  • Creating stable jobs capable of supporting families in the decarbonized future

Click here to learn more about how GeoSolarPlus works.

Management Team

The GST leadership and management team includes some of the world’s most experienced and respected leaders in the fields of decarbonization and sustainable homes.

Stone Douglass is the Chairman and CEO of GST. He is a seasoned, 30-year public company executive and former Chairman and CEO of the Piper Aircraft Company.

Brent Mosbarger is the company’s Co-Founder and leads its commercial operations. He is a highly respected solar engineer whose experience includes roles with Chevron Energy’s green operations and serving as project manager and executive for a $400 million solar/geothermal innovation project.

Peter Romenesko is a Senior Strategic Advisor with GST. He brings to the company considerable experience as an engineer and large-scale project manager for Johnson Controls and Siemens.

Dr. Norbert Klebl is the company’s Co-Founder and Development Director. Recognized as one of the world’s leading experts in the field of zero-carbon innovation, he is a former McKinsey partner of 16 years with an MBA from Columbia.

Dar-Lon Chang is GST’s Director of New Product Development. Prior to joining GST, he had a 16-year career with ExxonMobil Energy Research. He received his PhD in engineering from the University of Illinois.

* Must be over 18, certain states are not currently available and will be added soon.

Recent News


SideChannel Inc. (OTCQB: SDCH)

The QualityStocks Daily Newsletter would like to spotlight SideChannel Inc. (OTCQB: SDCH).

It is estimated that as a result of the COVID-19 pandemic,cybercrime, including theft, data hacking, and destruction, grew by600%, forcing nearly every industry to embrace new cybersecuritysolutions

Cybercrime is projected to cost companies worldwide an estimated$10.5 trillion annually by 2025, up from $3 trillion in 2015.However, the hefty upfront cost associated with protectingbusinesses from these attacks is leaving most SMBs vulnerable

SideChannel acknowledges this issue, and through its team of vCISOsand vCPOs, it is lowering the barrier of entry to accessfundamental cybersecurity services, ultimately providing a robustyet affordable solution

By doing so, the company is playing a pivotal role in improvingcybersecurity attack readiness while making robust cybersecuritysolutions more accessible and affordable, particularly to SMBs

SideChannel (OTCQB: SDCH), a company founded on the belief that all enterprises, big orsmall, can have top-tier security guidance at a manageable cost,recognizes the current cost-prohibitive issue with cybersecuritysolutions, and seeks to address it by offering affordable androbust cybersecurity support. In addition, the company acknowledgescybersecurity as a growing concern, and the inability of small andmid-sized businesses (“SMBs”) to access associated services is anissue that needs to be addressed, lest many be put out of business.

SideChannel Inc. (OTCQB: SDCH) simplifies cybersecurity for mid-market companies by matching them with highly experienced information security officers at a cost lower than building an in-house information security team or hiring a full-time CISO.

SideChannel’s team of virtual Chief Information Security Officers (vCISOs) possesses a combined 400-plus years of experience in cybersecurity. They’ve honed their skills and abilities in places like Anthem, Dick’s Sporting Goods, Best Buy, TD Bank and the Pentagon. SideChannel lends this talent to clients, creating value in the form of a bespoke cybersecurity program perfectly sized for the growing enterprise.

SideChannel is committed to creating top-tier cybersecurity programs for SMBs to help them protect their data and assets. To date, SideChannel has created more than 50 multi-layered cybersecurity programs for its clients.


Reports show that cyberattacks on SMBs have increased in recent years, as organizations’ network attack surfaces have grown exponentially with remote and in-office workers increasingly relying on cloud environments, mobile devices, software applications and third-party suppliers to conduct business.

SideChannel continues expanding its service offerings, workforce and customer base, attracting over 20 virtual CISOs to serve across industries including fintech, biotech, healthcare, manufacturing, legal, defense and technology services. The company is based in Worcester, Massachusetts.

Market Opportunity

An analysis from ReportLinker states that the global cybersecurity market is expected to grow from an estimated value of $173.5 billion in 2022 to $266.2 billion by 2027, recording a CAGR of 8.9% for the period.

The increased number of data breaches worldwide, the ability of malicious actors to operate from anywhere in the world, the links between cyberspace and physical systems, and the difficulty of reducing vulnerabilities and consequences in complex cyber networks are some factors driving cyber security market growth, according to the report.

A lack of cybersecurity professionals and the budget constraints among SMBs and start-ups in developing economies are expected to hinder market growth. Cybercriminals are using automated techniques to attack SMBs’ networks to take advantage of their weak security infrastructures. To save money, time and resources, SMBs are seeking cybersecurity solutions.


Enclave expands upon SideChannel’s cybersecurity service offerings by solving a pervasive network security problem with a simple tool.

A comprehensive cloud and network security solution, Enclave enables IT teams to contain breaches faster, reduce network outages, minimize latency and strengthen overall security defense.

Enclave creates the foundation for a Zero Trust network security model IT can build upon.

With Enclave, IT can easily segment their company’s network, organize personnel and computing devices at the employee workload level, and implement security controls across all network segments.

Enclave was designed and purpose built to serve the growing security needs of SMBs, a traditionally underserved market that is more prone to cyberattacks but has limited protection due to smaller budgets, inadequate IT security staffing and a lack of cybersecurity awareness among top executives.

Enclave is an affordable and effective network security solution that shrinks the attack surface area exposed to a cyber intruder and significantly reduces the amount of effort required to operate securely.

Management Team

Brian Haugli is CEO of SideChannel. He has led programs for the U.S. Department of Defense, the Pentagon, and Fortune 500 companies. He is an expert on National Institute of Standards and Technology guidance, threat intelligence implementations and strategic organizational initiatives. He is a professor at Boston College, Woods College of Advancing Studies Master’s Program in Cybersecurity. He is also a contributing author for the Wiley book ‘Cybersecurity Risk Management’.

Ryan Polk is CFO at SideChannel. He has been the principal of Perissos Partners, an executive consulting firm, since June 2017. He also served in executive roles in the portfolio companies owned by Lacy Diversified, with combined revenue approaching $2 billion. He served as the Vice President for Corporate Financial Planning and Analysis for Brightpoint, a publicly traded, Fortune 500 mobile device logistics company. He earned a bachelor’s degree in accounting and industrial management from Purdue University.

Nicholas Hnatiw is Chief Technology Officer at SideChannel. Prior to joining the company, he served as the technical director for network operations supporting U.S. Cyber Command, U.S. Intelligence Agencies and other Department of Defense research organizations. He was also the CEO of Loki Labs, a cyber security firm. He earned a bachelor’s degree in computer engineering and computer science at the University of Massachusetts, Amherst.

Bill Roberts is SideChannel’s CISO. He most recently served as the vice president, IS & CISO for Hologic Inc., a global medical device company, where he established cyber security and IT compliance programs. Prior to Hologic, he was vice president of information security for Cytyc Corporation, which was acquired by Hologic in 2007. At Cytyc, he managed global IT as the company grew from 140 employees to 1,500 and from $40 million in revenue to over $750 million.

SideChannel Inc. (OTCQB: SDCH), closed Tuesday's trading session at $0.0781, even for the day. The average volume for the last 3 months is and the stock's 52-week low/high is $0.0412/$0.18.

Recent News

Progressive Care Inc. (OTCQB: RXMD)

The QualityStocks Daily Newsletter would like to spotlight Progressive Care Inc. (OTCQB: RXMD).

Progressive Care (OTCQB: RXMD), a personalized healthcare services and technology provider, isreporting financial results for the fiscal year ended Dec. 31,2022. Highlights of the report include an increase in total revenueto $40.6 million, representing a 5% growth from the prior year,with pharmacy revenue increasing by $2.5 million, or 7%, and 340Bcontract revenue totaling $3.8 million for the year, an increase of$1 million from the year before. The company reported gross profitmargin of approximately 24% in 2022, compared to approximately 26%in 2021, along with the completion of a capital raise with NextPlatCorp, resulting in approximately $5.4 million net proceeds; thecapital raise provided for the restructuring of the company’sconvertible debt, including an interest rate reduction from 10% to5%. Operational highlights included the appointment of Charles M.Fernandez as chairman of the board of directors and CEO, with theappointment of Rodney Barreto as board vice-chair. In addition,RXMD secured long-term care contracts with all major payors andannounced a technology partnership with MedAvail to offer remoteprescription medication dispensing. The company’s wholly ownedsubsidiary ClearMetrX also launched its 340MetrX platform toprovide 340B covered entities with data insights to enable enhancedoperation and maximization of the 340B program.

To view the full press release, visit

Progressive Care Inc. (OTCQB: RXMD) is a health services organization based in Florida that offers personalized healthcare services and technology that supports the managed healthcare industry. Through its subsidiaries, Progressive Care provides Third-Party Administration (TPA), data management and analytics, COVID-19 diagnostics and vaccinations, 340B contracted pharmacy services, compounded medications, tele-pharmacy services, dispensing of anti-retroviral medications, medication therapy management (MTM), long-term care facility-targeted prescription medications, and health practice risk management.

The company collaborates with various healthcare organizations such as managed care organizations (MCOs), management services organizations (MSOs), accountable care organizations (ACOs), primary care providers, Medicare Advantage plans, Medicaid, commercial payors, pharmaceutical manufacturers, and distributors to enhance patient and provider engagement while improving the lives of patients with chronic diseases. Progressive Care offers a wide range of innovative solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs.

Progressive Care currently operates four pharmacies in Florida, which generate the majority of its revenue. Pharmacy revenue is derived from dispensing medications, third-party administrative services to 340B-covered entities, and MTM services. The company also provides customized management, patient health risk reviews, and free same- and next-day delivery. Its focus is on complex chronic diseases that require multiyear or lifelong therapy, driving recurring revenue and sustainable growth. Progressive Care’s pharmacy revenue growth stems from its expanding breadth of services, new drugs coming to market, new indications for existing drugs, volume growth with current clients, and addition of new customers resulting from its emphasis on higher patient engagement, free delivery to the patient, and clinical expertise.

With licenses in 14 states, Progressive Care is poised for national expansion. The company anticipates revenue growth by signing new contract pharmacy service and data management contracts with 340B-covered entities, expanding data management and analytics services to healthcare organizations, and potential acquisitions.


Progressive Care’s wholly-owned subsidiaries provide services to client organizations and patients.

PharmcoRx Pharmacy

PharmcoRx, a full-service pharmacy, provides a complete healthcare ecosystem with services such as medication therapy management, rapid COVID-19 testing and vaccines, contactless medication delivery, Smart-Pack Unit Dosing packaging, custom compound medications, specialty medications, hospital transition pharmacy services, medication adherence monitoring, medication adherence risk management, and drug cost containment. PharmcoRx Pharmacy is a contracted pharmacy services provider for 340B-covered entities under the 340B Drug Discount Pricing Program.


ClearMetrX, a wholly-owned data management company, offers services that support healthcare organizations across the country. In September 2022, ClearMetrX launched the 340MetrX Platform, a software product developed by ClearMetrX that provides 340B-covered entities with data insights to effectively operate and maximize the benefits of the 340B program. 340MetrX supplies data access and delivers actionable insights that providers and support organizations can use to improve their practices and patient care. Its TPA services include management of wholesale accounts and contract pharmacies, patient eligibility with regard to the 340B drug program, development and review of 340B policies and procedures, and management of receivables.

Market Opportunity

According to an industry report by global consulting firm Berkeley Research Group, gross sales across the 340B drug program were valued at $116 billion in 2021 and are projected to grow to $280 billion by 2026, achieving a CAGR of more than 19% over the period.

The 340B drug pricing program allows eligible healthcare clinics and hospitals (the covered entities) to purchase outpatient drugs at a 20-50 percent discount to treat low-income, uninsured, or underinsured populations. The program’s forecast growth is expected to benefit Progressive care’s business of providing 340B program services to covered entities through the nationwide expansion of ClearMetrX, its third-party administration and data-management business.

Management Team

Charles M. Fernandez is CEO and Chairman of the Board of Directors of Progressive Care. Mr. Fernandez is also the Executive Chairman and CEO of NextPlat Corp. (NASDAQ: NXPL) and has over 30 years of experience in identifying profitable start-up and dislocation opportunities, building significant value and executing exit strategies as an entrepreneur and global investor. In 2008, he joined Fairholme Capital Management. As president, he co-managed all three Fairholme funds and was commended for bringing in a $2 billion gain for shareholders. Throughout his impressive career in media, pharmaceuticals, healthcare, finance and technology, Mr. Fernandez has participated in more than 100 significant mergers, acquisitions and product development projects. He was the founder, chairman and CEO of eApeiron Solutions LLC, a brand protection and e-commerce company in partnership with Alibaba (NYSE: BABA) and Eastman Kodak (NYSE: KODK) which was successfully sold to Smartrac, a leading developer, manufacturer and supplier of RFID and Internet of Things (“IoT”) solutions and a unit of Avery Dennison Corporation (NYSE: AVY).

Other top management team members include Chief Operating Officer Birute Norkute, Chief Financial Officer Cecile Munnik, and Pamela Roberts, who serves as the company’s Pharmacist in Charge.

FingerMotion Inc. (RXMD), closed Tuesday's trading session at $3.45, off by 4.1667%, on 4,000 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $3.00/$10.40.

Recent News

Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF)

The QualityStocks Daily Newsletter would like to spotlight Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF).

Eloro Resources (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM) today provided an update on its ongoing preliminary metallurgicaltestwork program for the Iska Iska silver-tin polymetallic projectin the Potosi Department, southern Bolivia. The ongoing work isbeing carried out by Blue Coast Research Ltd. (“BCR”) based inParksville, British Columbia, and Mineral Concentration Laboratoryof the National Faculty of Engineering from the TechnicalUniversity of Oruro (“UTO”), Bolivia. “The Iska Iska silver-tinpolymetallic deposit is a remarkably extensive system with multiplepotential ore types, which require more metallurgical work thanoriginally anticipated, especially for tin, as outlined in thispress release,” said Tom Larsen, CEO of Eloro. “The preliminarymetallurgical recovery estimates are a prerequisite for the releaseof the project’s maiden mineral resource (‘MRE’). Consequently, therelease of the MRE has been delayed until this metallurgical work,which is in progress, has been completed. All other work requiredfor the MRE has been largely completed by Micon InternationalLimited, including much of the reporting.”

To view the full press release, visit

Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF) is a publicly traded exploration and mine development company with a portfolio of gold and base-metal properties in Bolivia, Peru and Quebec.

The company has an option to acquire a 99% interest in the highly prospective Iska Iska Property, classified as a silver-tin polymetallic epithermal-porphyry complex, a significant mineral deposit type in the Potosi Department of southern Bolivia. Iska Iska is a road-accessible, royalty-free property.

Eloro also owns an 82% interest in the La Victoria Gold/Silver Project, located in the North-Central Mineral Belt of Peru, some 50 kilometers south of Barrick’s Lagunas Norte Gold Mine and Pan American Silver’s La Arena Gold Mine. La Victoria consists of eight mining concessions and eight mining claims encompassing approximately 89 square kilometers. La Victoria has good infrastructure, with access to road, water and electricity, and is located at an altitude that ranges from 3,150 meters to 4,400 meters above sea level.

The company has a strong management and technical team working diligently to uncover the value of both Iska Iska and La Victoria. Eloro is based in Toronto, Canada.


Iska Iska – Potosi, Bolivia

Iska Iska is associated with a Miocene possibly collapsed/resurgent caldera, emplaced on Ordovician age rocks with major breccia pipes, dacitic domes and hydrothermal breccias. The property is wholly controlled by the title holder, Empresa Minera Villegas S.R.L. It is located 48 kilometers north of Tupiza city, in the Sud Chichas Province of the Department of Potosi. This is an important mineral deposit type in the prolific South Mineral Belt of Bolivia. Eloro commissioned a NI 43-101 Technical Report on Iska Iska, which was completed by Micon International Limited and is available on Eloro’s website and under its filings on SEDAR.

A fully financed drill program is currently underway on the property, situated near world-class deposits including Silver Sand, San Bartolomé, Pulacayo, San Cristobal, San Vicente, Chorolque, Tasna, Choroma and Siete Suyos. Iska Iska is in the southwest part of the Eastern Cordillera, which hosts a number of major polymetallic mines and mineral deposits. Drilling and continuous channel sampling results have demonstrated some very high metal values, especially silver and tin, within an immense system, where mineralization has been encountered in every drill hole to date. The company believes there is excellent potential for world-class bulk mineable deposits.

La Victoria – Ancash, Peru

The La Victoria project, targeting gold and silver production, is situated near world-class, low-cost gold producers Pan American Silver and Barrick Gold Corporation. Located in Ancash Department, La Victoria sits on the western slopes of the Peruvian Andes. The property is located 12 hours from Lima, with a travel distance of 600 kilometers. The nearest road accessible population centers from La Victoria are Huandoval, Pallasca and Cabana. The project includes four principal mineralized zones in Peru’s prolific North-Central Mineral Belt – San Markito, Victoria, Victoria South and Ccori Orcco – with excellent potential for gold discovery. Operations at La Victoria are planned to proceed with a 2,000-meter diamond drilling program to test targets to outline potential resources at San Markito. Trenching and sampling confirmed high silver values and veins at San Markito in 2020.

Market Outlook

According to industry association The Silver Institute, the outlook for silver demand is exceptionally promising, with global demand forecast to rise to a record high of 1.112 billion ounces in 2022. The increase will be driven by record silver industrial fabrication, which is forecast to improve by 5%, as silver’s use expands primarily in solar energy and electric vehicle (EV) manufacturing. The institute states that government commitments to carbon neutrality have resulted in a rapid expansion of green energy projects, driving record photovoltaic panel installations which are expected to lift silver demand in this segment to an all-time high in 2022.

Rising demand in the electronics industry is also boosting the demand for tin, which is primarily used in solder. The electronics and electrical industries use solders containing 40-70% tin, which provide strong and reliable joints under a variety of environmental conditions. At present, the majority of the assemblers are using patented tin-and-copper-based solders. Mordor Intelligence estimated tin demand at 387 kilotons in 2021 and forecasts demand growth of 2.5% annually through 2027. Over the medium term, surging demand from the EV market and increasing applications in the electrical and electronics industry is expected to drive the market.

Management Team

Thomas G. Larsen is CEO of Eloro. He has more than 40 years of experience in the investment industry, specializing in corporate finance and management of junior resource companies, raising in excess of C$200 million. He previously held the position of President and Chief Executive Officer of Champion Iron Limited. Prior to that, he was President and Chief Executive Officer of Champion Iron Mines Limited.

Dr. Bill Pearson is Executive VP of Exploration for Eloro. He has more than 40 years of direct experience in the exploration and production of minerals worldwide. He played an integral role in the acquisitions of Desert Sun Mining Corp. by Yamana Gold in 2006 and Central Sun Mining by B2 Gold in 2009. He was formerly VP Exploration at Desert Sun Mining and Senior VP at Central Sun Mining.

Miles Nagamatsu, CPA, is CFO at Eloro. He has over 30 years of experience in accounting, management, lending, restructurings and turnarounds. Since 1993, he has acted as a CFO of public and private companies primarily in the mineral exploration and investment management sectors. He holds a Bachelor of Commerce degree from McMaster University.

Osvaldo Arce Burgoa is General Manager at Eloro. He is a geological and mineral processing engineer with 26 years of experience in Bolivia. He is a former President of the Bolivian Geological Society, Main Technical Advisor of the National Mining Corporation (COMIBOL) and has served as exploration manager and chief geologist at various mining and exploration companies. He has authored two books on Bolivian geology and holds a doctorate in mining engineering from Tohoku University in Sendai, Japan.

Eloro Resources Ltd. (OTCQX: ELRRF), closed Tuesday's trading session at $2.69, off by 2.8881%, on 108,595 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $2.09/$4.19.

Recent News

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV)

The QualityStocks Daily Newsletter would like to spotlight BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV).

A study by Stanford Medicine researchers has revealed thatindividuals with eczema or asthma have a higher chance of developing osteoarthritis. The findings suggest the presence of an allergic pathway thatcould be treated with existing drugs. Scientists have traditionallythought that wear and tear in the cartilage that protects jointsand bones are the primary reason behind osteoarthritis. However, the Stanford Medicine study found that inflammation mayalso play a key role in developing the condition. Researchers fromStanford Medicine teamed up with scientists from the BostonUniversity School of Medicine, the VA Palo Alto Health Care Systemand Seattle-based Chinook Therapeutics to study risk factors for osteoarthritis.Osteoarthritis is a type of arthritis that affects more than 50million people in America. It is more likely to affect older andobese people, has no known cure and often causes disabilities. Itis characterized by joint pain, stiffness, swelling, tenderness andloss of flexibility. In the meantime, many enterprises such as BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) are devoting considerable resources toward searching forimmunotherapy protocols that can help patients with autoimmuneconditions lead better lives.

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) is a biopharmaceutical company focused on developing, manufacturing and commercializing innovative products for the prevention and treatment of infectious diseases and other illnesses.

In collaboration with the prestigious Max Planck Institute for Multidisciplinary Sciences (MPG) and the University Medical Center Göttingen (UMG), both in Germany, BiondVax is developing a pipeline of innovative nanosized antibody (NanoAb) therapies addressing diseases underserved by current treatments and with large and growing markets, such as COVID-19, asthma and psoriasis.

NanoAbs, also known as VHH-antibodies or Nanobodies, are alpaca-derived nanosized antibodies that exhibit multiple significant competitive advantages over existing antibody therapies, including stability at high temperatures, superior binding affinity, more effective and convenient routes of administration and efficient production. BiondVax is uniquely positioned to advance nanosized antibody innovation from R&D through commercialization.

The company’s highly experienced and successful pharmaceutical industry leadership team includes former senior executives from Novartis, GSK and Bristol-Myers Squibb.

Since its founding, BiondVax has executed eight clinical trials, including a seven-country, 12,400-participant Phase 3 trial of a prior influenza vaccine candidate, and it built, owns and operates a 20,000 sq. ft. state-of-the-art GMP biologics manufacturing facility housing its laboratories, production facilities and offices.

Lead Candidate: Inhaled COVID-19 NanoAb

In December 2021, BiondVax signed definitive agreements with the Max Planck Society – parent organization of the Max Planck Institute for Multidisciplinary Sciences– and the UMG to enter a strategic collaboration for the development and commercialization of innovative COVID-19 NanoAbs.

The company is planning a rapid development path that leverages its expertise and capabilities in biological drug development and manufacturing. BiondVax anticipates preclinical proof-of-concept results for an inhaled COVID-19 NanoAb by the end of 2022, with initial Phase 1/2a human clinical trial results expected in 2023.

The intended inhaled mechanism of delivery of BiondVax’s COVID-19 NanoAb formulation may serve as a significant differentiator when compared to approved monoclonal antibodies, which are injected. Inhaled delivery has shown to be cheaper, more convenient and likely safer for patients and providers.

NanoAb Pipeline: Psoriasis, Asthma and More

The COVID-19 NanoAb development agreement is part of a broader five-year research collaboration agreement signed in March 2022 covering discovery, development and commercialization of NanoAbs for several other disease indications with large market medical needs, including asthma, psoriasis, macular degeneration and psoriatic arthritis.

BiondVax has an exclusive worldwide license for development and commercialization of COVID-19 NanoAbs and exclusive options for similar worldwide licenses for NanoAbs for the above mentioned additional large market disorders currently underserved by approved therapeutic antibodies.

Academic research teams from MPG and UMG have verified strong affinity by the new NanoAbs to their biological target molecules and high thermostability. They have also demonstrated strong neutralization by several NanoAb candidates of their respective target molecules. Neutralization studies of the other NanoAbs are expected to begin later in 2022.

Based on the promising results, BiondVax will focus development efforts beginning with the following NanoAbs:

  • NanoAbs targeting IL-17 as drug candidates for the potential treatment of psoriasis and psoriatic arthritis
  • NanoAbs targeting IL-13 and NanoAbs targeting TSLP as drug candidates for the potential treatment of asthma

These are conditions for which the antibody target is validated by existing treatments and the mechanism of action is well understood. Both represent large medical needs and growing markets. BiondVax anticipates preclinical proof-of-concept for at least one of these NanoAbs in 2023. This is in addition to the aforementioned human clinical Phase 1/2a for the inhaled COVID-19 NanoAb therapy, which is also anticipated in 2023.

Market Opportunity

COVID-19 treatment, target of the company’s lead NanoAb therapy candidate, had an estimated market size of $22 billion in 2021.

Future BiondVax drug candidates will target conditions with large markets growing at attractive CAGRs.

The global asthma treatment market was valued at $18.08 billion in 2019 and is projected to reach $26.01 billion by 2027, exhibiting a CAGR of 4.5% during the forecast period, according to Fortune Business Insights. The research firm predicts that the global psoriasis treatment market will grow from $26.37 billion in 2022 to $47.24 billion by 2029, exhibiting a CAGR of 8.7% over the forecast period.

Management Team

Amir Reichman is BiondVax’s CEO. He previously was Head of Global Vaccines Engineering Core Technologies at GSK Vaccines in Belgium. Prior to that, he held leadership roles at Novartis Vaccines’ Global Vaccines Supply Chain Management organization. He was the first employee of NeuroDerm Ltd., a company focused on transdermal drug delivery, and served as Chief Engineer and Senior Scientist until his departure in 2009. He earned a M.Sc. in Biotechnology Engineering from Ben-Gurion University and an MBA in Finance and Health Care Management from the University of Pennsylvania’s Wharton School.

Tamar Ben-Yedidia, Ph.D., is Chief Science Officer at BiondVax. She has more than 30 years of experience in immunology, with specific expertise in the development of vaccines. She began her career with Biotechnology General Ltd., working on development of a recombinant Hepatitis-B vaccine. She later joined the Weizmann Institute of Science, working on the design of a peptide-based vaccine against several pathogens. She is widely published, with numerous refereed articles and invited reviews in various scientific journals. She received her Ph.D. from the Weizmann Institute.

Elad Mark is COO at BiondVax. He has over 15 years of biotechnology industry experience encompassing diverse project stages including feasibility studies, conceptual and detailed design, commissioning, qualification and process validation. Prior to joining BiondVax, he led Novartis’s $800 million investment in a biologics facility in Singapore. With Biopharmax and Antero, both global pharmaceutical engineering companies, he successfully led projects in Israel, China and Singapore. He holds a BSc. in Engineering from the Afeka Tel Aviv Academic College of Engineering and an MBA from the Open University of Israel.

Uri Ben-Or is CFO at BiondVax. He has served as CFO with public life science companies traded on the TASE, OTC and Nasdaq. Ben-Or provides his services to BiondVax through CFO Direct, a company he founded and for which he serves as CEO. He served as the VP of Finance of Glycominds, a leading biotechnology company, and as CFO of a spin-off from Telrad Networks. He also served as a Corporate Controller at Menorah Capital Markets and as an Auditor at PWC. He holds a B.A. in Business from the College of Administration, an MBA from Bar-Ilan University, and is a CPA.

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV), closed Tuesday's trading session at $1.96, off by 2.9703%, on 41,661 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $1.96/$19.65.

Recent News

Cepton Inc. (NASDAQ: CPTN)

The QualityStocks Daily Newsletter would like to spotlight Cepton Inc. (NASDAQ: CPTN).

Cepton, Inc. recently published its 4Q22 and FY22 financial results

The company revealed that it had generated FY22 revenues of $7.4million, up by 65% relative to FY21 results. Furthermore, Ceptonguided for FY23 revenues of $15-20 million

Cepton is at the forefront of lidar technology development, aposition they’ve further consolidated with the recent launch oftheir award-winning Vista® X-120 Plus sensors

Cepton (NASDAQ: CPTN), a Silicon Valley innovator and pioneer within high-performanceMMT® lidar solutions, recently announced their financial resultsfor the fourth quarter and full year ending December 31, 2022 ( The company reported full year 2022 revenues of $7.4 million,within the target guidance provided by Cepton earlier in the yearand equivalent to a 65 percent increase year over year. Meanwhile,full year GAAP net income was equivalent to $9.4 million or $0.06per share. During their release, Cepton provided guidance for their2023 figures, forecasting full year 2023 revenues to come in atbetween $15 million to $20 million; meanwhile, the company revealedthat they expected 2023 operating expenses to be in line with2022’s results (i.e., $61.4 million).

Cepton Inc. (NASDAQ: CPTN) is a provider of state-of-the-art, intelligent, lidar-based solutions serving a range of markets, including automotive (ADAS/AV), smart cities, smart spaces and smart industrial applications. General Motors (NYSE:GM) has granted a series production award for Cepton’s lidar, the biggest such award to date in the automotive space. Cepton’s is the lidar component of GM’s Ultra Cruise autonomous driving platform. By leveraging its patented Micro Motion Technology (MMT®) lidar platform, the company develops reliable, scalable and cost-effective solutions that deliver long-range, high-resolution 3D perception for smart applications.

Cepton was established in 2016 by co-founders Dr. Jun Pei and Dr. Mark McCord. The company is headquartered in San Jose, California, and serves a fast-growing customer base through an international presence spanning North America, Germany, Japan, India and China.

Micro Motion Technology (MMT®)

Cepton was built from the ground up to meet key lidar industry challenges for mass market adoption. This company’s portfolio of proprietary technology is uniquely aimed at facilitating this industry growth through a combination of performance, reliability, affordability and design integration.

Key among its innovations is MMT®, a mirrorless, frictionless, rotation-free 3D imaging platform designed specifically for lidars. Its benefits for OEMs and system integrators include:

  • Reliability – The durable design uses common, easily attainable materials.
  • Versatility – The platform is capable of achieving near- to ultra-long range with a wide field of view.
  • Efficiency – MMT® features a compact form factor, low power usage and inexpensive components.
  • Scalability – Its simple design means that scale-up to high manufacturing volumes is easily attainable.

Because of their compact form factor, Cepton lidars are embeddable and ideally suited for advanced driver-assistance system (ADAS) integration, whether behind windshield, in headlamp or in fascia.

Agreement with KOITO

KOITO Manufacturing Co. Ltd., the world’s premier Tier 1 auto lighting supplier, originally started an evaluation of Cepton’s MMT® based lidars in 2018. In 2020, KOITO made an investment in Cepton aimed at accelerating the company’s development and enabling KOITO’s industrialization of high-performance and high reliability lidar sensors for ADAS and autonomous vehicle (AV) applications.

Through this collaboration, Cepton was able to secure the largest ADAS lidar series production award[1] with General Motors as a sole source in the automotive space. The award covers GM vehicles for the initial period of 2023-2027.

On August 5, 2021, the two companies deepened their relationship when KOITO committed to invest a further $50 million in Cepton’s business through its participation in a Private Investment in Public Equity (PIPE) offering of shares of common stock of Growth Capital Acquisition Corp. in connection with Cepton’s recent merger.

Collaboration with GM

On July 13, 2021, Cepton announced that it had secured an ADAS lidar series production award from a leading, Detroit-based global automotive OEM – the biggest lidar production award by any OEM to any lidar company. It was later clarified that the OEM was General Motors, and Cepton’s lidar is part of GM’s ADAS Ultra Cruise system.

GM is “expected to deploy Cepton lidars in its next generation of advanced driver assistance systems (ADAS) across multiple vehicle classes and models – not just luxury cars.” As such, the agreement marks the potential for “an industry-first, mass-market adoption of lidar technology for automotive ADAS, with an anticipated deployment in consumer vehicles starting in 2023.”

On July 28, 2021, Ford Motor Company (NYSE: F) distributed an article on Medium noting, “Ford has been engaged with Cepton almost since their inception in 2016, both for R&D collaboration and small-scale deployments. Cepton LiDAR are deployed in some of [Ford’s] smart city projects. Based on Ford’s guidance, Cepton delivered a custom version of their LiDAR to enable R&D on advanced ADAS features.”

Market Outlook

Driven by increasing development and adoption in automobile safety applications, environmental mapping and 3D-modeling, the global lidar market is forecast to experience considerable growth over the coming years. A research report published by MarketsAndMarkets suggests that the sector will grow to an estimated $3.4 billion by 2026, achieving a CAGR of 21.6% over the next five years.

The report further highlights increasing investments in lidar startups by automotive giants as a driver of growth opportunities in the sector, particularly in North America.

In 2020, ground-based lidar accounted for the lion’s share of the overall lidar market, and this trend is expected to continue as the automotive sector continues to rapidly advance adoption across the full spectrum of vehicle classes. One factor not to be underestimated is the high barrier of entry and the exceptionally long time required for automotive OEMs to vet and award a production win to a lidar company. It is a commonly held view that the over 50 lidar companies will inevitably coalesce into a handful serving all OEMs.

Cepton, having a head start through its established partnership with leading global OEM GM, is uniquely positioned to capitalize on this market growth in the years to come.

Management Team

Cepton’s founder-led team is made up of lidar industry pioneers with decades of collective experience across advanced lidar and imaging technologies.

Jun Pei, Ph.D., is the company’s CEO and Co-Founder. He is a technology specialist with a focus in optics and electronics. Prior to founding Cepton, Dr. Pei founded AEP Technology, a firm focused on developing advanced 3D optical instruments. He received his Ph.D. in electrical engineering from Stanford University.

Mark McCord, Ph.D., is Cepton’s CTO and Co-Founder. Prior to founding Cepton, he led advanced development at KLA-Tencor. Dr. McCord also formerly served as an associate professor at Stanford University, where he earned his Ph.D. in electrical engineering.

Winston Fu, Ph.D., is the company’s CFO. Dr. Fu is the founder of Silicon Valley venture capital firm LDV Partners. Prior to joining Cepton, he served as CFO and Chairman of Active-Semi before its acquisition. Dr. Fu has also helped to build many technology companies as an entrepreneur and/or board member. He received his Ph.D. in applied physics from Stanford University, as well as an MBA from the Kellogg School of Management at Northwestern University.

[1] Largest known ADAS lidar series production award based on number of vehicle models awarded

Cepton Inc. (NASDAQ: CPTN), closed Tuesday's trading session at $0.46, off by 1.7724%, on 164,246 volume. The average volume for the last 3 months is 160,233 and the stock's 52-week low/high is $0.403/$4.17.

Recent News

India Globalization Capital Inc. (NYSE American: IGC)

The QualityStocks Daily Newsletter would like to spotlight India Globalization Capital Inc. (NYSE American: IGC).

A recent study by Australian researchers has revealed a dramaticincrease in the number of Australians using medical cannabis.Researchers from the Lambert Initiative at the University of Sydney found that even though mostAustralians still use illicit cannabis as a therapeuticalternative, medical marijuana prescriptions have risensignificantly. The Cannabis as Medicine Survey (CAMS20) quizzed1,600 Australians on their medical cannabis use from September 2020to January 2021. Its findings were published in the “Harm Reduction Journal.” The poll found that 37% of participants had received a medicalcannabis prescription within the survey period compared to the 2.5%of respondents who had medical cannabis prescriptions during theprior Cannabis as Medicine Survey (CAMS18), which ran from 2018–2019.This growing use of cannabis for medicinal purposes in Australiaand around the world suggests that there may be demand for thecannabis-based medicines that companies such as India Globalization Capital Inc. (NYSE American: IGC) are developing.

India Globalization Capital Inc. (NYSE American: IGC), through subsidiary IGC Pharma, develops, patents, and markets advanced THC-based drug formulations for the treatment of symptoms related to various diseases including but not limited to Alzheimer’s disease, Tourette syndrome, chronic pain, and pet seizures.

IGC’s leading drug candidate, IGC-AD1, has completed Phase 1 of a safety and tolerability trial and entered Phase 2 trials for treating agitation in patients with Alzheimer’s dementia, the first study in humans of a natural tetrahydrocannabinol (THC) compound plus another molecule ( As of September 2022, the IGC trial is the only ongoing Phase 2 trial of a natural THC-based formulation on Alzheimer’s patients.

The company’s other drug candidate, TGR-63, is an enzyme inhibitor that has shown in preclinical trials the potential to reduce neurotoxicity in Alzheimer’s cell lines. Both drug candidates have shown their ability to ameliorate beta amyloid plaques in Alzheimer’s cell lines and improve memory in Alzheimer’s mouse models. Beta amyloid plaques are a key hallmark of Alzheimer’s and an important target of Alzheimer’s pharmaceutical drug development.

Neuro Psychiatric Symptoms (NPS) are not only debilitating for Alzheimer’s patients; they also place an immense emotional burden on their caregivers. Beyond reducing symptoms, IGC-AD1’s active molecules and TGR-63 have also shown promise in preclinical trials to reduce important hallmarks of Alzheimer’s including plaques and tangles, as well as improving the treatment of memory loss.

Over the past eight years, the IGC team has amassed a deep knowledge of cannabinoid science, including extraction, isolation, purification, and development. The company’s strategy is to leverage its unique end-to-end capabilities, platform, and expertise to develop a class-leading program and bring it to market quickly and cost efficiently to treat neurodegenerative diseases such as Alzheimer’s.

The company also has a family of cannabidiol (CBD)-based consumer products ( such as pain relief creams, pain relief gels, purpose gummies, tinctures, and capsules targeting women’s wellness, with a particular focus on premenstrual syndrome (PMS) and dysmenorrhea (period cramps). In addition, the company targets individuals that need sleep-aids with its specially formulated low melatonin cannabinoid gummies.

IGC has also introduced a low-calorie CBD- and caffeine-infused energy beverage brand ( that is currently available for purchase. The company’s brands are founded on the belief that effective natural solutions should be affordable and accessible to everyone. As the demand for natural products targeting women’s wellness and energy drinks continue to grow, these products are seeing strong traction in the market.

The company operates three facilities – a large GMP (Good Manufacturing Production Standards) certified facility that includes extraction, distillation, and manufacturing, in Washington State; a GMP-211 (pharmaceutical) grade facility in Maryland; and a facility licensed for controlled substances including cannabis in Bogota, Colombia, with complete access to legal licensed cannabis where the company conducts its testing.

In addition, the company’s development under Magistral Formulations is approved by INVIMA (Colombia National Food and Drug Surveillance Institute) to treat neurological disorders, non-oncological chronic pain, and mental disorders.

IGC’s intellectual property (IP) portfolio comprises of eight patents that it controls and seven patent applications. The portfolio includes #11,446,276, a patent for extreme low dose THC treatment of Alzheimer’s that was granted in September 2022.

The company is headquartered in Potomac, Maryland.


IGC-AD1 is the company’s leading drug candidate for the treatment and relief of Alzheimer’s symptoms. A significant amount of research on Alzheimer’s cell lines has shown that the active agents in IGC-AD1 reduce plaques and neurofibrillary tangles that are the hallmarks of Alzheimer’s. Further, micro-dosing of THC, as shown in cell lines, could increase the functioning of mitochondria and potentially promote the growth of new neural pathways (neurogenesis). The research shows that micro-dosing of THC affects the brain radically differently from the normal higher dosing of THC.

While there is a significant body of research showing that THC is neuro-toxic at normal levels of dosing, micro-dosing of THC has been shown to be non-toxic to neurons. With the results of these preclinical studies, the company developed an oral formulation, IGC-AD1. The company recently completed a safety and tolerability Phase 1 trial on Alzheimer’s patients and has initiated a Phase 2, multi-site, double-blind, randomized, placebo-controlled trial of the safety and efficacy of IGC-AD1 on agitation in participants with dementia due to Alzheimer’s disease at sites in the U.S. and Canada. IGC expects the Phase 2 trial to take between 9 and 12 months to complete, barring unknown factors such as, for example, a resurgence of COVID and the enforcement of lockdowns and travel restrictions.

With further successful trials and FDA approvals, IGC hopes to bring a drug based on natural THC as an effective treatment for agitation in Alzheimer’s to market.


The company’s other molecule, TGR-63, has been shown to reduce the neurotoxicity that impacts memory loss in preclinical trials with mice. On a dose dependent manner, transgenic Alzheimer’s mice treated with TGR-63 showed improvement in memory relative to control.

Both drug candidates, IGC-AD1 and TGR-63, have shown their ability to reduce the brain plaques associated with memory loss in Alzheimer’s in mice.

With further successful trials and FDA approvals, IGC hopes to bring TGR-63 as a treatment for Alzheimer’s disease to market.

Market Opportunity

Alzheimer’s disease impacts over 55 million people worldwide and about 5.5 million individuals in the U.S. Over 70% of these patients face debilitating symptoms, including anxiety, depression, and agitation (Mendez, 2021). Agitation in dementia patients can include excessive physical movement and verbal activity, restlessness, pacing, belligerence, aggression, screaming, crying, and wandering.

In 2020, the estimated healthcare costs for Alzheimer’s disease in the U.S. were $305 billion. Medicare and Medicaid covered about 70% of those costs, leaving considerable burden on patients and families. At the current rate of growth of Alzheimer’s and other dementia diagnoses, those costs are estimated to reach over $1 trillion by 2050.

Currently, there are no FDA-approved medications to alleviate the symptoms of dementia due to Alzheimer’s disease, providing a tremendous opportunity for formulations that can have an impact on quality of life and disease progression.

Management Team

Richard Prins has been chairman at IGC since 2012 and served as an independent director since 2007. From March 1996 to 2008, he was the Director of Investment Banking at Ferris, Baker Watts, Incorporated. Prins served in a consulting role to RBC until January 2009. He currently volunteers full time with a non-profit organization, Advancing Native Missions, and is a private investor. Since February 2003, he has been on the board of Amphastar Pharmaceuticals Inc. He holds a bachelor’s degree from Colgate University and an MBA from Oral Roberts University.

Ram Mukunda is CEO and President of IGC. He has been the chief inventor and architect of most of the company’s patent filings and is responsible for the company’s strategic positioning. Prior to IGC, he was founder and CEO of Startec Global Communications, which he took public in 1997. He served as Strategic Planning Advisor at Intelsat, a communications satellite services provider. From 2001 to 2003, he was a Council Member at Harvard’s Kennedy School of Government, Belfer Center of Science and International Affairs. He was named the 1998 Ernst & Young Entrepreneur of the Year. He holds bachelor’s degrees in electrical engineering and mathematics, and a master’s degree in engineering from the University of Maryland.

Dr. Jagadeesh Rao is the company’s Principal Scientist. His career spans two decades in the public sector and product R&D for Johnson & Johnson. He leads IGC’s scientists in the development of pharmaceutical and OTC products. He worked for the federal National Institutes of Health, and for the National Institute on Drug Abuse. His Ph.D. in Neurochemistry is from the National Institute of Mental Health & Neurosciences in India. He did postdoctoral training at the University of Illinois-Chicago.

Claudia Grimaldi is a Director, Vice President, Principal Financial Officer, and Chief Compliance Officer for IGC. She also serves as a Director/Manager Director for some of the company’s subsidiaries. She graduated with highest honors from Javeriana University in Colombia with a bachelor’s degree in psychology. She holds an MBA, graduating with highest honors, from Meredith College in North Carolina. In addition, she has attended the Darden School of Business Financial Management Executives program and the Corporate Governance Program at Columbia Business School. She is currently pursuing her Directorship Certification with the National Association of Corporate Directors. She is fluent in both English and Spanish.

India Globalization Capital Inc. (NYSE American: IGC), closed Tuesday's trading session at $0.3353, off by 3.483%, on 44,807 volume. The average volume for the last 3 months is 42,905 and the stock's 52-week low/high is $0.2785/$0.95.

Recent News

Mullen Automotive Inc. (NASDAQ: MULN)

The QualityStocks Daily Newsletter would like to spotlight Mullen Automotive Inc. (MULN).

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, hassuccessfully concluded a 60-day commercial EV pilot programwith Menzies Aviation and Loop Global Inc. at the Los AngelesInternational Airport (“LAX”). Menzies currently operates in250-plus airports in 58 countries to provide ground, air cargo andfuel services to commercial airports and airlines. During the pilotprogram, Menzies used two class 1 EV vans at the airport totransport both equipment and personnel, powering the vehicles withLoop-installed level 2 chargers. The vans drove more than 1,500miles during the program, with a reported 100% uptime and zeromaintenance issues. According to the announcement, the vansresulted in an estimated cost savings of 66% in electrical versusgas-equivalent vehicles with an estimated 83% reduction in CO2emissions compared to gas-vehicle equivalent vehicles. Followingthe program, Menzies has requested some van modifications, such asincreased seating capacity and additional windows, with MULNanticipating that vehicles with these enhancements will be used toexpand the Menzies fleet around the world. “The LAX pilot was veryimportant in quantifying the efficiency, uptime and cost savingsthat can be achieved with our class 1 EV vans,” said MullenAutomotive CEO and chair David Michery in the press release.“Successful pilots such as this demonstrate how companies can scaletheir fleet operations with commercial EV offerings from Mullen.”Mullen also announced that it is accelerating the integration ofsolid-state polymer battery technology into its commercial class 1EV cargo van program. According to the company, the integrationwill result in an increase in range from 110 miles to more than 200miles on a single charge; the company noted that the first cargovan test vehicles equipped with the solid-state polymer technologywill be ready for testing by Q4 2023. The current cargo vanfeatures a 46-killowatt lithium-ion battery pack. “The LinghangGuochuang Holding Group Co. Ltd. partnership with Mullen bringsnext-generation LH solid-state battery technology to the forefrontof vehicle production,” said Linghang Guochuang Holding Groupgeneral manager, new energy power business department, Yao Wang inthe press release. “Our partnership accelerates the world’s use ofsolid-state polymer battery technology, not only on the vehiclelevel but at all levels. We are pleased to be the first company inthe U.S. to implement LH solid-state polymer battery technology ina commercial vehicle in conjunction with Mullen Automotive.” Toview the full press releases, visit and

Mullen Automotive Inc. (NASDAQ: MULN) is a Southern California-based automotive company that owns and partners with several synergistic businesses working toward the unified goal of creating clean and scalable energy solutions. Mullen has evolved over the past decade in sync with consumers and technology trends. Today, the company is working diligently to provide exciting EV options built entirely in the United States and made to fit perfectly into the American consumer’s life. Mullen strives to make EVs more accessible than ever by building an end-to-end ecosystem that takes care of all aspects of EV ownership.

Commencement of Trading on Nasdaq

On November 5, 2021, Mullen announced its commencement of trading on the Nasdaq Capital Market.

“Today is a monumental day for Mullen Automotive. I am especially proud of our team, investors and all who have believed in Mullen and taken us to this point as a publicly traded company on the Nasdaq Capital Market,” David Michery, CEO and Chairman of Mullen Automotive, stated in the news release. “Trading on Nasdaq now opens us up to new investors, both institutional and retail shareholders, and broadens our awareness and company profile, while increasing awareness of Mullen and our technology platform and opening new opportunities in EV and beyond. The road ahead has never been brighter for Mullen, and I am proud to lead us into the future.”

The milestone came in the wake of the company’s stock-for-stock merger with Net Element Inc.

The Mullen FIVE

The Mullen FIVE EV Crossover, debuting at the Los Angeles International Auto Show (LAIAS) on November 17, 2021, embodies Mullen’s Southern California roots with an inspired design focused on two complementary Golden State themes – California landscape and California urban.

The FIVE is built on an EV Crossover skateboard platform that offers multiple powertrain configurations and trim levels in a svelte design that is Strikingly Different™ and exciting to experience in person.

Prior to the start of LAIAS, the Mullen FIVE was selected as a finalist by the LA Auto Show for Top EV SUV in the ZEVA “People’s Choice” Awards.

LAIAS provides Mullen an opportunity to display multiple variants of the FIVE model while also showcasing its powertrain, battery and charging technology. The company intends to bring the FIVE to market in 2024, and reservations are currently open here.

Mullen’s development portfolio also includes EV Fleet Vans, which it intends to bring to market in Q2 2022, and the pure electric, high performance Mullen DragonFLY.

Expansion of Manufacturing Capacity

On November 2, 2021, Mullen announced plans to expand its facility in Robinsonville, Mississippi.

Mullen’s Advanced Manufacturing and Engineering Facility (AMEC) currently occupies 124,000 square feet of manufacturing space. The total available land on the property is over 100 acres, and Mullen is moving ahead with plans to build out another 1.2 million square feet of manufacturing space to support class 1 and class 2 EV cargo vans and the Mullen FIVE EV Crossover.

On the expanded site, Mullen plans to build a body shop, a fully automated paint shop and a general assembly shop.

EV Market Outlook

The global EV market was reported to consist of 3,269,671 units in 2019, a figure that is expected to grow at a CAGR of 21.1% through 2030 to a total of 26,951,318 units worldwide. This market’s monetary value was estimated at $162.34 billion in 2019 and is expected to grow at a CAGR of 22.6%, resulting in an approximate value of $802.81 billion by 2027. The primary driver for this exponential growth is a worldwide increase in vehicle emissions regulations.

Management Team

David Michery is the CEO and Founder of Mullen and has been leading the company and its divisions since inception in 2014. With over 25 years of executive management, marketing, distressed assets, and business restructuring experience, Mr. Michery brings a wealth of relevant knowledge and expertise to the Mullen brand. He has notably created 12 trademarks so far to develop the company brand and vision.

Mr. Michery is working toward a sustainable future accessible to all by creating a suite of clean-energy electric vehicles at varied price points. With entirely U.S.-based manufacturing and operations, he is also determined to have Mullen Technologies play a role in shaping a self-sustaining local economy by creating more jobs in America.

Mr. Michery manages risks and company expectations as a pathway to success and has personally overseen several businesses that totaled over $1 billion in transactions. His key strength is the ability to be fiscally responsible and lead teams to complete projects on time and within budget. As a seasoned professional in this space, Mr. Michery has demonstrated skill in building businesses from the ground up and into successful entities that subsequently sold for hundreds of millions of dollars.

Mullen Automotive Inc. (MULN), closed Tuesday's trading session at $0.1052, off by 4.3636%, on 260,174,223 volume. The average volume for the last 3 months is 255.24M and the stock's 52-week low/high is $0.0887/$3.12.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.